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Parkinson's Disease 1 
Introduction 
It has been estimated that in the United States alone, approximately 1 in 100 
people over the age of 50 will be affected with Parkinson's disease (Duvosin, 1984 ). 
Parkinson's disease (PD) is a crippling, neurodegenerative condition that consists of a 
triad of physical symptoms: tremor, rigidity, and bradykinesia (Dakof & Mendelsohn, 
1986; Wooten, 1990). In addition to these three core symptoms, patients with PD often 
experience other disease-related problems, including cognitive impairment (e.g., deficits 
in memory and language), and psychological distress (e.g., depression, anxiety; 
Growden, Corkin, & Rosen, 1990). Although symptom severity can drastically fluctuate 
from day to day and can be temporarily managed with medication, gradual deterioration 
of the patient's health and cognitive status is inevitable. A diagnosis of PD represents 
for the patient the prospect of a diminishing ability to accomplish simple activities of daily 
living such as walking, eating, dressing, and writing. The anticipation of such a 
deterioration in capacity and continuing health degradation can often result in the patient 
feeling both helpless and hopeless about the future (e.g., Dakof & Mendelsohn, 1986). 
Decreased ability to perform tasks can affect several facets of the patient's life. 
For example, activities such as going to the store or visiting friends becomes difficult as 
decreased motor control and weakness impedes normal functioning. As a result, the 
individual with PD may experience some indirect consequences of the disease such as 
social anxiety, a lack of motivation and/or stress-dependent increases in motor difficulty 
(Ellgring et al., 1993). These conditions, as well as the disease symptoms themselves, 
may lead to a gradual decrease in the participation of activities that are social in nature 
(e.g., dining out, involvement in community activities). 
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Numerous studies have focused on the psychological impact of PD on the 
identified patient {Seiler et al., 1992; Dakof & Mendelsohn, 1986; Ellgring et al., 1993). 
More specifically, clinical depression is the most often reported psychological 
disturbance identified in patients with PD {Gotham et al., 1986). An estimated 50% of 
Parkinson's patients report significant levels of clinical depression {Leiberman, 1992). It 
is unknown, however, whether depression in individuals with Parkinson's is independent 
of the disease, a consequence of the neurobiological concomitants {i.e., 
neurotransmitter dysfunction), reactive in nature {i.e., emotional reaction to the 
permanent, debilitating nature of the disease) or some combination of these factors 
(Seiler et al., 1992). Further, it assumed that other symptoms associated with a 
depressive state (e.g., anxiety, decreased ability to concentrate) will occur more 
frequently in individuals experiencing a chronic illness (Ehman, Beninger, Gawel, & 
Riopelle, 1990). Although seemingly important, few studies have examined the 
relationship between both general adjustment and more specific mood states (e.g., 
depression) reported by individuals with PD and their functional status (Merriman, Owen, 
Chew, & Tan, 1994; Santamaria, Tolosa, & Valles, 1986). 
It is believed that various factors including, stage of disease, functional ability, 
and use of particular coping strategies may contribute to both general and depression-
related symptoms (e.g., anxiety, decreased ability to concentrate). For example, 
individuals identified as moderately functionally impaired by the PD condition who report . 
few depressive type symptoms may utilize particular coping strategies that result in the 
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reduction of these symptoms. A thorough examination of individuals affected (both 
directly and indirectly) by the PD condition with decreased levels of general and specific 
mood states could provide beneficial information regarding factors that may lead to 
poorer levels of overall adjustment. 
Regardless of the cause, the presence of adjustment difficulties and depression 
may further contribute to difficulties in the patient's overt physical condition that ultimately 
effects his/her functional status. Previous research in the field of behavioral medicine 
has clearly shown the connection between psychological distress (coping and 
adaptation following disease diagnosis) and physical well-being (Larsen, 1990; Palmore 
& Luikart, 1972; Seiler et al., 1992). This research has demonstrated that the stressors 
experienced in daily life profoundly influence the patient's psychological state (i.e., 
depression, anger, feelings of hopelessness). More specifically, it appears that the 
impact of the physical and psychological aspects of PD are circular; a diagnosis may 
lead to an anticipated loss of functioning (psychological distress) which negatively 
influences the patient's physical condition (i.e., compromised immune system 
functioning). For example, individuals with PD who are depressed may evidence 
decreased motor activity, which, in tum, can impact physical health and feed back into 
one's negative perceptions regarding his/her current state of affairs {i.e., not feeling 
good about self due to inactivity). Given the supporting data on psychological stressors 
increasing one's susceptibility to illness (Ellgring et al., 1993) and diminishing one's 
capacity to perform basic activities of daily living, it appears critical to evaluate the 
contributing factors to such distress in order to develop appropriate clinical interventions. 
One area of research regarding the psychological aspects of PD has involved an 
examination of the coping strategies utilized by identified patients. Coping is defined as 
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.an effortful process of adapting to potentially challenging, threatening or harmful 
circumstances associated ·Nith a disease condition (Pearlin & Schooler, 1978). 
Numerous authors have-investigated the association betv,een the coping strategies {i.e., 
thoughts or actions) employed by individuals with a chronic illnes.s and the impact of 
utilizing such strategies on psychological adjustment (e.g., Felton & Reverson, 1984; 
Hainsworth, Eakes, & Burkes, 1994). A variety of coping responses (e.g., information 
seeking, avoidance, seeking comfort from others, wish-fulfilling fantasy) have been 
associated with stressors accompanying specific disease conditions such as diabetes 
(e.g., Marrero, 1981), PD (e.g., Ehmann; Benninger, Gawel, & Riopelle, 1990), and 
rheumatoid _arthritis (e.g., Lambert, 1981). Despite extensive research regarding 
individual coping responses to health-related stressors, there is a paucity of information 
regarding the specificity of their use according to the type a_nd severity of the stressor 
encountered, the characteristics -of the individual employing the strategies, or the extent 
to which the response used attenuates the stressful situation (Moos & Billings, 1980). 
Further, an examination of the relationship between demographic variables (e.g., age, 
education, occupation) and method of coping utilized is warranted as it may provide 
critical information as to the utility of particular intervention strategies with particular 
patients. 
Additional studies have focused on the coping strategies utilized by caregivers 
and their reported levels of psychological well-being (Quayhagen & Quayhagen, 1988; 
Stephens et al., 1988). Whereas both the patient and caregiver literature individually 
address the relationship between use of specific strategies and reported levels of 
psychological adjustment, no research has synthesized these areas to determine if the 
strategies independently employed by the patient and the caregiver influence each 
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other's level of adjustment. More specifically. certain strategies employed by patient and 
caregiver dyads may facilitate the adjustment process, while other combinations may 
hinder it. An examination of this type of information gleaned from patient-caregiver 
dyads could provide information critical for the development of beneficial interventions. 
It is believed that such interventions could promote circular patient and caregiver well-
being (i.e., the more positively adjusted the caregiver feels, the better care they provide 
for the patient, which ultimately effects the patient's perception of well-being, and vice 
versa). 
The ability to effectively cope with a chronic illness is additionally influenced by 
the predictability of the disease condition. Research with other disease states (e.g., 
cancer; Patterson, 1981), has demonstrated that chronically ill individuals who 
experience increased levels of uncertainty (i.e., they are less able to predict the outcome 
of the disease state) report diminished levels of overall adjustment to the condition. 
Previous work by Webster and Christman (1988) demonstrated a relationship between 
increased levels of uncertainty and use of affectively driven coping strategies, with lower 
levels of uncertainty being related to increased use of problem-focused coping methods. 
Overall, uncertainty in illness has been found to be a robust predictor of adjustment 
processes across a variety of disease states ( e.g., Mullins, Chaney, Hartman, & Pace, 
1997). 
Thus, the purpose of the current research was as follows: 1) to identify the type 
of coping style predominantly used by patients and caregivers, 2) to identify the 
relationship between the coping strategies predominantly used by patients and his/her 
caregivers and their reported level of general adjustment and depression, and 3) to 
identify the relationships between level of uncertainty and the level of general adjustment 
I 
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and depression reported by patients and their respective caregivers. Additionally, 
exploratory analyses were conducted to determine: 1) the combined relationship of 
patient and caregiver variables (i.e., coping strategy, functional ability, level of 
uncertainty) to general adjustment and depression, and 2) the reciprocal influence of 
patient participants' general adjustment, coping strategy, and uncertainty on caregiver 
adjustment (and vice versa). 
The following will be a review of the literature regarding Parkinson's disease, 
coping and adjustment to a chronic illness, and information regarding the caregivers and 
support systems of individuals afflicted with a chronic illness. First, the pathogenesis of 
Parkinson's disease is presented, followed by the physiological and psychological 
aspects of the condition. Next, an overview of the coping research regarding the patient 
and his/her caregivers/support systems will be provided. Finally, the research questions 
posed in the current study are specified. 
Review of the Literature 
History and Pathogenesis 
In 1817, James Parkinson recognized a constellation of symptoms occurring 
among certain individuals characterized by resting tremors, abnormal posture, and 
difficulties in gait. These physical symptoms appeared to run a progressive course that 
was degenerative in nature (Parkinson, 1814). Parkinson believed that although the 
patient's physical· condition appeared to deteriorate as a result of the disease, the 
"senses and intellect" remained intact. Further, Parkinson identified other psychological 
consequences of the disease, including demoralization and "increasing debilitation that 
causes the influence of the will over the muscles to fade away" (Parkinson, 1814, p.8). 
It was also recognized that patients differed both in their adaptation to the disease, and 
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how the disease affected their ability to complete the activities of daily living (e.g., 
irritability, diminished hand writing skills, difficulties with gross motor movements). 
Parkinson's initial description of the psychological sequelae surrounding 
Parkinsonianism was later elaborated upon by many researchers and clinicians, who 
subsequently elucidated concomitant conditions of the disease, such as depression, 
stubbornness, and irritability (Ball, 1812; Konig, 1912; Oppenheim, 1908; all as cited by 
Mjones, 1949). 
Two separate perspectives, termed the "psychosomatic" and the 
"somatopsychic" viewpoints, evolved in relation to the etiology of the psychological 
conditions associated with Parkinson's disease. Researchers supporting the early 
"psychosomatic" position believed that the conditions underlying Parkinson's disease, 
both physical and psychological in nature, occurred as a result of intrapsychic conflict 
(Patrick & Levy, 1922). The psychosomatic proponents hypothesized that psychological 
trauma or loss predisposed individuals to the disease and that the motor symptoms 
identified with the disease were actually physical manifestations of suppressed 
unconscious hostility (Je!!iffe, 1940). Je!!iffe likened the typical Parkinsonian stance to 
that of a "boxer or wrestler prepared to battle their opponent" (Jelliffe, 1940, p.33). This 
stance purportedly represented hostility and a preparedness to lash out aggressively. 
Contemporary research and knowledge of the disease process, however, suggest that 
the psychosomatic interpretation of Parkinson's disease was grossly inadequate and 
credulous. This perspective, however, was historically important in that it represented 
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an era that failed to acknowledge the bicct:emical processes underlying various medical 
and psychological conditions (e.g., migraine headaches, ulcers). Knowledge of the 
physiological mechanisms of PD were not adequately gleaned or understood until the 
1960's (Praag, 1979). 
In contrast to the psychosomatic perspective, the viewpoint of individuals 
favoring the "somatopsychic" perspective was ahead of its time. Such adherents 
believed that the psychological symptomatology demonstrated by individuals with 
Parkinson's disease was a result of the disabling nature of the disease itself. Wilson 
( 1921) suggested that the psychological symptoms of the disease were the "natural 
outcome perhaps of an incurable disease ... explicable by the nature of the ailment" (p.7). 
The somatopsychic perspective hypothesized that while the motoric difficulties identified 
in patients with Parkinson's disease were organically based, they had a significant effect 
on the patient's family relations, concept of self, and emotions. The social and 
psychological impairments that occurred in Parkinsonian patients were expected and 
were regarded as secondary reactions to the primary physical symptomatology of the 
disease (Machover, 1957; Diller & Riklan, 1956}. Such psychological symptoms were 
viewed as normal "psychopathology'' that occurred in relation to the pattents' inability to 
perform tasks that were previously standard functions of daily life. This view was later 
supported by Riklan, Weiner & Diller(1959), who found that patients with more severe 
physical impairments were significantly more emotionally distressed. 
During the 1960's and 70's, research investigating the neurochemical 
underpinnings of Parkinson's disease began to flourish. Of importance was the 
examination of the role of one particular neurotransmitter, dopamine, in the symptoms 
identified as Parkinsonian in nature. The role of dopamine was elucidated by three 
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major findings: a) discovery of dopamine in the substantia nigra, b) significantly less 
dopamine in the substantia nigra of people who had died from Parkinson's in 
comparison to individuals who had died of other causes, and c) evidence that 
Parkinson's patients treated with large doses of L-dopa (i.e., direct precursor of 
Dopamine which boosts activity at dopaminergic synapses) demonstrated a significant 
temporary reduction in identified symptoms. These discoveries resulted in a transition in 
clinical examination of the psychological/physical conditions of Parkinson's disease from 
one focusing on the psychosocial correlates to one with biomedical underpinnings. 
Structural Pathology 
With the advent of scientific technology [e.g., Magnetic Resonance Imaging 
(MRI), Positron Emission Tomography (PET), immunocytochemical methods], the brain 
structures affected by Parkinson's disease have become better understood (e.g., Martin 
& Palmer, 1989). Five anatomically and functionally interconnected subcortical 
structures, collectively called the basal ganglia, appear to be associated with Parkinson's 
disease (Emson et al., 1989; Young & Penney, 1988). The components of the basal 
ganglia include the caudate nucleus, putamen (neostriatum), the globus pallidus 
(intema! and external segments), the subtha!amic nucleus, and the substantia nigra. 
The most .identifiable overt physical anomalies, which can only be recognized 
post-mortem, are located in the substantia nigra. The pathological manifestations of PD 
in the substantia nigra include; 1) degeneration and loss of pigmented neurons in the 
pars compacts (subdivision of the substantia nigra), and 2) the presence of Levvy and 
hyaline bodies. Typically, 60-80 percent of the nigral striatal neurons have degenerated 
in patients demonstrating the characteristic symptoms of PD. For patients in the 
advanced stages of the disease, or those who have a long history of PD (Roberts, 
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Leigh, & Weinberger, 1-993), nigrostriatal deterioration may almost be complete. Lewy 
and hyaline bodies are composed of free fatty acids, polysaccharides, proteins, .and 
sphingomyelin. Among individuals with PD, Lewy and hyaline bodies appear 
intraneuronally as halo encapsulated bodies of radially arranged filament material of 
approximately 5-10nm in diameter (Jellinger, 1989). Although the presence of Lewy 
bodies are a tell-tale sign of PD (essential for post-mortem pathological diagnosis of PD), 
such anomalies are identified in approximately 5 percent of the normal population (Le., 
not diagnosed with PD) of individuals over 65 who experienced no PD-type symptoms 
during their lifetime (Roberts et al., 1993). An increased presence of Lewy bodies inhibit 
the appropriate interrelated functioning of the substantia nigra and the other components 
of the basal ganglia, and ultimately leads to the physical characteristics of PD (Wooten, 
1990). 
Pathophysiology 
The basal ganglia {i.e., neostriatum, globus pallidus, subthalamic nucleus, 
substantia nigra) are highly interconnected with other areas of the brain such as the 
neocortex, the ventral thalamus, and the superior colliculus. For individuals with PD, the 
influence of the basal ganglia's neurochem!cal output, via the ventral anterior and ventral 
lateral thalamus, on the areas of the cortex is of significance. Here, the 
neurophysio!ogical functioning (or malfunctioning) of these localized mechanisms [i.e., 
hyperactivity (i.e., over activity) or hypoactivity (i.e., inhibition of activity)] is directly 
associated with the obser,1able triad of PD symptoms. The relationships between the 
structures of the basal ganglia, and the influence of their output on the cortex via the 
nigro-striatal pathway will be discussed so as to elucidate the pathophysiological 
mechanisms of PD (Delwaide & Gonce, 1993). 
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The neostriatum receives inputs from the central cerebral cortex, and projects 
this information (via the pallidal and nigral systems) to the thalamus, which in turn 
projects to the neocortex(Young & Penney, 1988). This communication system is 
termed-a regulatory loop whereby the subthalamic nucleus forms a reciprocal pathway 
(glutamatergic) with the globus pallidus (Delwaide & Gonce, 1988). Some information 
leaving the basal ganglia utilizes a different pathway. Efferent neurons branching from 
the pars reticulata of the substantia nigra (SNR) project directly to the peduncular 
pontine nucleus and superior colliculus, which directly effect the brain stem reticular 
formation (associated with cortical tone and certain aspects of posture) and systems 
regulating eye movements. The neostriatum also receives afferent projections from the 
pars compacta of the substantia nigra (SNC), and from the ventral tegmental area 
[(VT A) (Beckstead, Bomesick, & Nauta, 1979)]. In Parkinson's disease, there appears 
to be a pathological increase in the activity of the projections from the neostriatum to the 
external segment of the globus pallidus. This increase in activity is with the neostriatal 
release from inhibition by the degenerated nigrostriatal pathway, which leads to an 
increase in excitatory output activity of the subthalamic nuclei (STN). The projection of 
STN neuronal activity to the internal and external segments of the globus pallidus is 
increased resulting in a surge of GABAergic neuronal firing from the Globus pallidus 
internal which ultimately suppresses neurons in the ventral thalamus (Penney & Young, 
1981). The communication which takes place within and across these structures are 
neurochemical in nature. These neurochemicals, called neurotransmitters, play a critical 
role in the interrelated functioning of the brain structures. Simplistically stated, changes 
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in neurotransmitter availability or the ability for neurons to appropriately communicate 
may result in the symptoms such as those identified with PD as the interrelated 
operations of the brain structures required for proper functioning have been altered. 
Neurochemical pathology of PD 
The dopamine hypothesis of PD was generated in the 1960's as a byproduct of 
the development of technology allowing researchers to examine the biochemical 
underpinnings of various diseases. Degeneration of specific dopaminergic neurons is 
identified in the pars compacta area of the substantia nigra. Ehringer and Hornykiewicz 
(1960) demonstrated that individuals with PD showed significantly reduced levels of 
dopamine concentration. Such dopamine deficiency in the neostriatal system (more 
specifically the putamen), conjointly with the demonstration of the triad of physical 
symptoms, provide the evidence for a PD diagnosis (an actual PD diagnosis can only be 
given post-mortem with identification of Lewy bodies). Routine Positron Emission 
Tomography (Pet) scans using F-dopa can easily detect such depletion in the caudate 
nucleus and the putamen. Whereas it is normal for dopamine levels to decrease as a 
function of age, the characteristic motoric symptoms of PD occur with accelerated nigral 
dopaminergic neuronal loss (50-70%) 'Nhich results in neostriatal dopamine levels to 
decrease by approximately 80 percent. Decreased dopaminergic activity in the striatum 
is believed to be associated with symptoms of PD such as akinesia (Hornykiewicz, 1966; 
Bernheimer, Birkmayer, Hornykiewicz, Jellinger, & Geitelberger, 1973), however 
research has failed to elucidate the actual physiologic role of the basal ganglia in 
producing such motor movement. 
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Etiology 
. PD symptoms appear to begin when approximately 80% of the dopaminergic 
neurons have been depleted .(Levin & Katzen, 1995). Three hypotheses have been 
developed to explain the "premature" deterioration of neurons in the substantia nigra 
th;at results in striatal dopamine depletion. First, a deficiency in the number of neurons in 
the substantia nigra could occur as a result of genetic irregularity (Lang, 1987). Such a 
genetic link has been refuted, however, due to a lack of evidence demonstrating either 
twin concordance or familial incidents of PD (Marttila, Kaprio, Kostenv~o. & Rinne, 1988; 
Ward et al., 1983). Second, it has been suggested that PD occurs as a result of an 
accelerated aging process in the brain. Research has demonstrated that individuals 
with PD have significantly fewer adequately functioning substantia nigra neurons (e.g., 
parts of the neurons may be missing a histone coat which leaves them vulnerable to 
mutagenesis), but such research is in it's infancy and few findings have been 
substantially supported empirically (Shapira et al., 1990a). A third hypothesis suggests 
that accelerated dopamine deficiency occurs as a result of a traumatic event (i.e., head 
injury, encephalitis; Godwin-Austen, Lee, Marmot & Stem, 1982; Mattock, Marmot, & 
Stem, 1988; Stem, Dulaney, & Gruber, 1991), or contact with an environmental toxin 
(Young & Perry, 1986). It is believed that such injuries do not, in and of themselves, 
cause PO, but may result in acute loss of neurons, which is subsequently compounded 
by the typical degradation of neuron functioning that occurs with age. 
Signs and symptoms 
PD symptoms emerge in an insidious, gradual manner and are often apparent 
initially as non-specific minor aches, pains, and cramping that may be identified as 
typical signs of aging (Marsden, 1994). The patient or his/her relatives may notice a 
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general "slowing" of fine motor movements in the hands (evidenced by small, 
increasingly unintelligible writing), gross motor movements of the body (difficulty in gait or 
dressing), and dexterity. A physician can typically diagnose PD merely by having the 
affected individual sit next to his/her unaffected spouse or partner (Liberman, 1992). 
The patient's characteristic facial appearance, body posture, and gait are easily 
discernible when placed next to a "normal" individual. 
Typical symptoms of PD include tremor at rest, akinesia, and rigidity (Delwaide & 
Gonce, 1988). Approximately 80% of individuals suspected of having PD exhibit tremor 
-at rest (usually in the hands) at some point during their illness. Unilateral and bilateral 
tremor, while an important diagnostic feature of PD, is but one of the requisite symptoms 
for a PD diagnosis. Rigidity, akinesia and bradykinesia, and postural and gait difficulties 
must be thoroughly assessed in order to differentially diagnose PD from other 
neurological disorders such as hemiparesis, supranuclear palsy, or stroke. Akinesia and 
bradykinesia refer to motor problems such as poverty of motor movement, decelerated 
motor movement, and difficulty in initiating movements that require dexterity. Stiffness 
or rigidity are other common symptoms demonstrated by individuals with PD that is 
evidenced by an increased resistance to passive limb and trunk movement. Problems 
with the lower extremities are a!so noted in abnormalities of gait and posture. Typically, 
individuals with PD demonstrate a hurried gate comprised of small shuffling steps 
interrupted by states of frozen stiffness. Such postural difficulties understandably result 
in an increased risk for falls. 
The progression of PD, and its resulting effect on an individual's motoric ability, 
has historically been categorically measured via a variety of disability rating scales. One 
of the most noted scales is the Hoehn and Yahr rating scale (e.g., Lee et al., 1994; 
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Maccarthy & Brown, 1989), developed in the late 1960's. This scale provides a 
relatively rough estimate of the stage of illness progression identified by gait disturbance, 
postural stability and functional disability (i.e., walking and falling). Affected individuals 
are categorized into one of five stages of illness advancement. At stage I, the patient 
exhibits only unilateral symptoms and minimal functional disability (e.g., weakness in one 
hand and no difficulties with ambulation). By stage V, severe impairment is noted and 
the patient is typically bed-ridden and completely dependent on others to maintain the 
tasks of daily living for him/her. Gotham, Brown, and Marsden (1988) further 
categorized patients utilizing this system by identifying stages I and II as mild, stages Ill 
and IV as moderate, and stage Vas severe. In general, the Hoehn and Yahr scales 
provides a means by which to classify disease progression in identified patients and thus 
allows for a common ground on which to make comparisons within and between groups 
of individuals afflicted by the disease. Based on the notion that individuals with PD 
experience a gradual and progressive decline in health that are both physical and 
emotional in nature, an examination across these domains is important in order to 
develop appropriate interventions targeting areas of potential decreased functioning. 
Treatment of PD 
Elucidation of the bicc.11emical process (dopamine hypothesis) underlying the 
physical symptoms of PD Jed to extensive research on pharmacological treatments fer 
PD symptoms. Some of these symptoms are believed to occur as a result of the 
neurotransmitter dopamine being "unavailable" in the synaptic cleft for transmission to 
subsequent neurons (Bemheimer et al., 1975; Wooten, 1990). Absence of dopamine in 
the cleft can occur as a result of the ingestion of drugs such as reserpine or 
tetrabenazine which block the vesicles that store dopamine leading to inhibition of it's 
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release. This explains how non-PD patients can demonstrate Parkinsonian type 
symptoms as particular medications prescribed for other medical conditions can result in 
behaviors that are overtly identical to those symptoms identified with PD (e.g., tardive 
dyskinesia, tremors). Accessibility of dopamine in the synaptic cleft can be mediated by 
pharmacological agents, such as 0-amphetamine and trihexyphenidyl, and can act as 
agonists by blocking the vesicles from which the dopamine was released. This process 
inhibits dopamine from rapid reuptake and thus allows for prolonged accessibility and 
action of dopamine in the cleft. Such treatment can only be beneficial, however, if 
sufficient !eve!s of dopamine are formed and, ultimately, released into the synaptic cleft. 
It is believed that the symptoms identified with individuals with PD typically occur in 
relation to the depleted levels of dopamine found in the neuronal tissues which 
decreases the availability of neurotransmitters for dispersal·by the vesicle. 
Although it would seem logical to treat Parkinson's patients by providing them 
with the neurotransmitter in which they are deficient, direct administration of dopamine is 
ineffective as the blood-brain barrier prevents the dopamine in the blood from crossing-
over into the brain. Currently, the overall drug treatment of choice for the dopamine 
insufficiency associated with PD is laevodopa (L-dopa). L-dopa is unaffected by the 
blood-brain barrier and is readily converted to dopamine by a substance, labeled 1-AAD 
(L-aromatic main acid decarboxylase), that is located in the brain. The effects of L-dopa 
are quite significant as it drastically reverses the triad of characteristic Parkinsonian 
symptoms [(i.e., tremor, bradykinesia, rigidity), (Melamed, 1988)]. The conversion of L-
dopa to dopamine, however, becomes jeopardized as dopaminergic neurons 
progressively die in PD patients, ultimately decreasing the number of potential sites for 
the conversion process to take place (Carlson, 1986). Thus, continuous treatment with 
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L-dopa appears to lose its effectiveness after approximately five years (Roberts et al., 
1993; Wooten, 1990). Future directions in pharmacotherapy for PD look towards the 
development of pharmacological agents that stimulate dopamine receptors without 
requiring metabolic conversion. Formulation of these agents, however, is in its infancy 
(Wooten, 1990). In essence, long-term pharmacological treatment for PD is currently 
non-existent. 
Although the biomedical research on the physical manifestations of PD has been 
conducted for less than fifty years, vast strides have been made in this area particularly 
concerning the possible reversal of PD symptomatology. During the years since the 
identification of PD as a chronic illness, other critical research has also been conducted 
in regards to the psychological substrates of the disease. The following sections are a 
review of the general research examining the premorbid personality factors and 
psychological sequelae of PD associated with PD. The role of these factors was 
examined in relation to their influence on the caregivers and patient's ability to adjust to 
the disease condition. 
PD "personality" and premorbid factors 
Theories associated with the underlying neurochemical mechanism of PD 
patients suggest that premorbid factors shape their affective state and, ultimately, their 
resulting personality structure. Research associated with the pre-morbid PD personality 
has proliferated over the last 30 years with the ultimate hope of identifying individuals at 
risk for the development of PD. Various factors identified as being linked to the 
development of PD include upholding rigid moral codes (Camp, 1913), the industrial 
revolution (Mitscherlich, 1960), "teetotaling," and unresponsive parents [(Prick, 1966), 
(as stated by Hubble and Koller, 1995). More specifically, these researchers believe that 
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a thorough examination of one's background could expose a history of behaviors that 
seemingly promoted the development of the conditions of PD. This research, while 
intriguing, has relied on ex post facto data (i.e., gathered historical information from 
patients following diagnosis) and is believed to be distorted by the patient's current level 
of functioning (Hubble & Koller, 1995). Empirically derived data regarding the 
development of a PD "personality" has yet to be found. 
Psychological seguelae of PD 
In addition to the physical sequelae of PD, individuals with PD also appear to 
suffer considerably from various psychosocial problems that emerge as secondary 
symptoms to their primary physical symptomatology (Ellgring et al., 1990). The most 
prominent of these psychosocial difficulties is clinical depression. Although depression 
is a typical feature of many chronic illnesses such as cancer (e.g., Weisman, 1979), 
stroke (e.g., VanderPlate, 1984), and multiple sclerosis (e.g., Beatty, 1993), research 
has demonstrated that individuals with PD report significantly higher levels of depression 
than patients with other disease conditions (Ehmann et al., 1990; Cartel! et al., 1986; 
Horn, 1974; Robins, 1976). Such findings, however, may be a function of the type of 
measure utilized to assess affect in each of these populations. Although not all 
individuals with PD evidence clinical levels of depression, prevalence rates average 
between 30% and 50% (Cummings, 1993; Lieberman et al., 1979; Mayeux, Williams, 
Stern & Cote, 1984). Brown and Jahanshahi (1995) suggested that the stage of the 
. individual's disease condition is related to prevalence rates as disruption of brain 
monoamines, which are the neurotransmitters implicated in the neurobiological basis of 
depression, become more severely effected with disease progression. Whereas the 
contribution of neurobiological factors to the presence of affective disturbance in PD is 
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supported in the literature (Cummings, 1993; Huber, 1992; Mayberg, Starkstein, & 
Sadzor, 1990), the degree to which these factors actually contribute to depressive 
symptomatology in PD patients is unknown. 
Brown and Jahanshahi (1995) suggest that the influence of individual 
psychological, unique medical (e.g., stage of illness, symptom severity), and general 
social factors on depressive symptoms in PD should be examined. These researchers 
hypothesize that psychological and social factors individually contribute to specific 
depressive symptoms in each patient at various stages of the disease process. 
Significant relationships, however, have only been identified between age of onset and 
depression (Starkstein et al., 1990; Gotham et al., 1988), rapid progression of disease 
symptomatology and depression (Brown, Maccarthy, Jahanshahi, & Marsden, 1989), 
and disability and depression (Starkstein et al., 1992). 
Overall, other studies in this area have provided contradictory res~lts, leading to 
the overall impression that disease-related factors are not always linked to the 
occurrence of clinical depression. It is suggested, however, that specific subgroups of 
PD (i.e., early onset, late stage) patients be more closely examined as they may be 
more vulnerable to affective disturbance. More specifically, these groups may be at risk 
for difficulties as they are either given a diagnosis that presents a grim future (i.e., early 
onset), or are experiencing a heightened expression of disease symptoms (i.e., late 
stage). Another explanation for the contradictory results may be the influence of other 
nondisease-related variables associated with the individual with PD (e.g., marital status, 
involvement in social activities) rather than a function of the disease condition itself. For 
example, divorced or single males diagnosed with PD may report higher levels of 
depressive symptoms than do their married counterparts. 
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Many debates continue to focus on whether depression occurs as a function of 
the biochemical underpinnings of PD or as a reaction to the diagnosis (Huber, 1992; 
Starkstein & Robinson, 1993). Regardless of the initial cause of the patient's 
depression, various factors in the patients' life can serve to propagate such feelings and 
ultimately intensify the patient's negative emotionality (e.g., chronicity of disease, 
impending deterioration, and increased inability to carry out typical daily functions). Due 
to the significant impact depression has on patient's overall well-being, the factors 
contributing to these depressive symptoms have been examined (e.g., Ehman, et al., 
1990; Horn, 1974; Maccarthy & Brown, 1989). These influences, including 
background characteristics (e.g., age, education level) and previous situational 
experiences (e.g., how an individual handled previous situations involving stress), will be 
discussed for purposes of understanding variables that may contribute to, or be 
correlated with, the PD condition. 
Throughout the course of a chronic illness, numerous problematic situations 
(e.g., variable changes in symptom presence, illness task demands, uncertainty 
associated with the illness) arise that necessitate the use of coping strategies by the 
patient and his/her caregiver. A close examination of the various types of coping 
responses used by individuals in stressful situations (e.g., chronic illness) and resultant 
levels of adjustment (i.e., depression) could provide critical information on the types of 
coping responses that lead to poorer overall adjustment. Whereas some research has 
investigated the use of particular coping strategies by individuals with PD (Ehmann et 
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al., 1990), these findings are not generalizable to all individuals effected by the disease 
condition. Thus, additional research is needed that investigates the use of particular 
coping strategies by individuals with PD. In the next section, literature on the use of 
coping strategies will be reviewed in relation to the PD condition. 
Coping literature 
The stress experienced by individuals with PD is hypothetically mitigated by the 
number and severity of symptoms present, the degree to which these symptoms 
interfere with daily task demands (e.g., work, family, social), availability and use of a 
support system, and the patients perception of disease manifestation (Blenner, 1992; 
Crawford & Mcivor, 1987; Gurkies & Menkes, 1988; Fennell & Smith, 1990; Larsen, 
1990; Matsen & Brooks, 1977; Pollack, Christian, & Sands, 1990; Wineman, 1990). The 
influence of these variables on resulting adjustment is believed to be mediated by the 
process of coping (Folkman & Lazarus, 1988; Warren, 1990). 
Coping has been defined as any belief or behavior that deals with some aspect 
of a situation evaluated by an individual to be taxing or exceeding his/her emotional or 
cognitive resources (Lazarus, 1993). Coping is a process whereby strategies are 
employed in the hopes to avoid the negative consequences (e.g., depression, stress) of 
encountering the conflicts and demands in life (Lazarus & Folkman, 1984; Pearlin & 
Schooler, 1978). Efforts have been made to classify these coping strategies as either. 
method-based or focus-based according to the intent or goal of the individual employing 
the strategy (Moos & Billings, 1981). Method-based coping is divided into active 
cognitive or behavioral strategies geared toward resolving the event (e.g., seeing the 
positives of the situation, seeking additional information), or avoidant responses 
whereby stress is reduced by avoiding active confrontation of the problem (e.g., keeping 
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feelings to yourself, engaging in eating or smoking behaviors to indirectly reduce 
tension). Focused-based coping is composed of two categories: problem-focused and 
emotion-focused coping (Lazarus, 1980; Pearlin & Schooler, 1978). Problem-focused 
coping strategies are geared towards modifying or eliminating the sources of stress 
through one's own behavior (e.g., identify a route to work that bypasses traffic and thus 
reduces stress), while emotion-focused strategies are geared towards venting feelings in 
order to regulate emotions in situations deemed unchangeable. Often this type of 
coping involves seeking support and assurance from others. Due to the amount of 
research on the problem- and emotion-based approaches in the chronic illness 
literature, the coping responses of interest to the present study will be limited to the 
focus-based system. 
Research has demonstrated that in situations involving generalized stressors 
(i.e., not specific to health issues), problem-focused coping is the most widely used 
strategy (Cohen & Lazarus, 1979). Folkman and Lazarus (1988) found that planful 
problem solving (problem-focused strategy) was associated with less negative and more 
positive emotions, unlike distancing (an emotion-focused strategy), which was 
significantly correlated with a negative emotional state. These researchers found that in 
certain situations involving significant long term health problems, emotion-focused 
coping strategies were more likely to be used than problem-focused strategies (Folkman 
& Lazarus, 1980). Lazarus ( 1993) suggests the rationale behind differential use of these 
strategies is associated with the situation's amenability to change; when stressful 
conditions are perceived as refractory to change, problem-focused strategies would be 
futile and thus emotion-focused coping predominates. Lazarus (1993) suggested that 
the efficacy of either strategy is dependent upon the particular person using it, the 
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stressor encountered, and what modality is being studied. More specifically, neither 
coping strategy should be identified as "good" or "bad"; rather, use of one strategy 
versus the other under some circumstances may result in better or worse adjustment. 
The efficacy of a coping strategy, be it problem-focused or emotion-focused in 
nature, is measured by the degree to which the perceived stress of the event is 
attenuated, not whether use of the strategy led to complete cessation of the stressful 
situation (Pearlin & Schooler, 1978). More specifically, individuals typically attempt to 
deal with the stress experienced within these situations as they arise, rather than 
attempt to decrease/control the likelihood of the event's occurrence, which, in the case 
of a chronic illness like PD, is impossible. How individuals cope may significantly impact 
the adjustment to stressful situations, including stress that arises as a function of having 
a chronic disease. Information on the use of particular coping methods used by patients 
and caregivers affected by PD may aid in the development of literature for use by these 
individuals to increase the likelihood of better general adjustment to the disease 
condition. To date, no research has investigated the relationship of coping strategies 
utilized by individuals with PD and their caregivers and overall adjustment. 
The ability of chronically ill patients to control or manage their symptoms, 
maintain a positive outlook, adjust to major role changes, and to feel "normal" is a 
constant, daily struggle. This struggle is further complicated by the uncertainty of their 
disease's cause or progression, and the severity of impending disability. Because PD is 
such an insidious and unpredictable disease, an examination of the role of perceived 
uncertainty and coping is critically important. 
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Uncertainty in Illness 
The perception of control an individual experiences in stressful situations is 
typically associated with the amenability of that situation to change, which is typically 
determined by the information available regarding the details of that event. With the 
appropriate amount of information, one can determine whether they will be able to 
control the consequences of an event and thus could act accordingly. For example, a 
work deadline is given for the end of the week for which I have adequate information to 
know what is expected, and can plan my schedule so that I can meet that deadline. In 
this example, an individual can predict with relative certainty the outcome of the event 
based on the information they possess regarding that situation. 
In situations associated with health related issues, uncertainty is defined as a 
person's inability to determine the meaning of the illness-related events. Uncertainty is 
described by Mishel and Epstein (1990) as a "cognitive state created when the person 
cannot adequately structure or categorize an event due to a lack of sufficient cues" (p. 
1 ). In these situations, the individuals directly or indirectly affected by the health issue 
cannot accurately predict the outcome of the condition (e.g., symptoms, severity of 
illness, impact on future). Whereas the notion of uncertainty has been examined with 
some disease conditions, such as Post-polio syndrome (Balderson, Sanders, & Mullins, 
1998), adult cancer (Patterson, 1981), adolescent cancer (Neville, 1998), and HIV/AIDS 
(Brashers, et al., 1998), no research has examined a PD population in regards to their 
use of emotion- or problem-focused coping strategies under conditions of perceived 
uncertainty. The current study will address this issue by surveying the patient and 
his/her caregiver's level of uncertainly regarding PD, and the relationship between 
respective levels of uncertainty and reported levels of adjustment. 
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In addition to the stress experienced by patients regarding the prospects of 
physical degradation and emotional maladjustment, is the awareness of the negative 
consequences that the disease condition may have on his/her significant others. 
Individuals in the initial .stages of PD may recognize that the progressive deterioration of 
the disease may result in their placing· a significant burden on immediate family 
members. As symptom severity increases, care providers are introduced to new and 
more encumbersome responsibilities that typically result in increased levels of emotional 
and physical stress. Although a seemingly important area of research, literature 
regarding the impact of caring for a chronically ill individual is in it's infancy. 
Caregivers/support systems 
The effects of an individual's chronic illness on his/her caregivers and/or family 
members are areas of research gaining more attention in recent years (e.g., Campas, 
Worsham, Ey, & Howell, 1996; Dura, Haywood-Niter, & Keicolt-Glaser, 1990; Lutzky & 
Knight, 1994). Several recent articles have focused primarily on the reciprocal impact of 
the patient-caregiver relations on general physical and emotion functioning (e.g., Shelly 
& Quittner, 1998; Williamson, Shaffer & Shelly, 1998). Caregiving to a chronically ill or 
disabled friend or family member is typically viewed as inducing stress that may place 
the caregiver at an increased risk for physical or emotional hardships (Campas et al., 
1990; Deimling & Bass, 1986; George & Gwyther, 1986; Speer, 1993). Strudiwick, 
Mutch & Dingwall-Fordyce (1990), found that of 227 PD patients, only 27% lived in a 
hospital or residential setting, while 73% of the remaining 173 patients required some 
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form of aid in completing his/her daily routine at home. Thus, based on previous 
literature, it appears that the majority of patients with PD reside with a caregiver, and, 
when coupled with the knowledge of the impending degradation of the afflicted 
individual, makes research in this area critically important. 
Tausing (1992) examined the influence of social networks and identified support 
systems on caregivers reported levels, and perception of burden. This research 
suggests that the level of support caregivers receive is a critical factor as it facilitates 
their being able to provide the required assistance to the chronically ill or disabled 
individual. Lutzky & Knight (1994) examined gender differences in caregiver distress. 
Of importance is their finding that male caregivers may be utilizing coping techniques 
that appear to result in decreased levels of depression and feelings of burden as 
compared to females caregivers. These researchers found that the majority of women 
tended to utilize emotion-focused coping strategies (e.g., avoiding confrontation, 
accepting personal blame, relying on social support), while men used more problem-
focused, direct methods of coping. Extrapolation of this data must be done cautiously 
however, as it may be confounded. More specifically, individuals identified as caregivers 
may differ in that male caregivers tend to be the spouse of the affected individual, while 
female caregivers are either wives or daughters (Lutzky & Knight, 1994). It is logical to 
assume that of the female caregivers, those who are daughters may encounter 
increased levels of stress as they may be confronted with other issues, such as role 
reversal with the chronically ill parent and attempting to maintain other life roles (e.g., 
wife, mother). 
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Carter and Carter (1994) and Dura et al. (1990) specifically examined spousal 
adjustment and spousal caregiving thereby eliminating all other relative caregivers. The 
Carter and Carter (1994) study focused on the effects of a chronic illness on marital 
adjustment and examined patient's health and gender as predictors of reactions to the 
disease condition. Results indicated that males who were married adjusted significantly 
better to the caretaker role than did single individuals, or females in general. Dura et al. 
(1990) examined spousal caregivers of PD patients with dementia to those of 
Alzheimer's patients with senile dementia (SDA T). Results from this study suggest that 
· caregivers of PD and SDA T patients did not differ on measures of distress regardless of 
SDAT's insidious onset and precipitous decline as compared to the gradual deterioration 
of PD. The similarities between these groups of care providers examined by Carter & 
Carter and Dura et al., could be a function of the likeness of symptoms demonstrated by 
patients afflicted with a chronic illness. 
Speer (1993) examined the relationships among PD patient's functional 
impairment and patient and caregiver psychosocial adjustment both cross-sectionally 
and longitudinally. The results of this study suggest that initial caregiver support, level of 
depression and sense of burden predicted patient's malaise, as defined by increase,d 
scores on the Sheikh and Yesavage Geriatric Depression Scale (1986) and the distress 
scale of the Duke-North Carolina Health Profile (Parkerson et al., 1981). Further, poor 
initial caregiver adjustment was negatively associated with the patient's sense of 
physical well-being over time. A relationship was also demonstrated between reported 
levels of patient and caregiver depression. Overall, this study was a preliminary attempt 
to individually examine both the patient and the caregiver with the intent of elucidating 
the relative influence of each individual's (patients and caregivers) adjustment on each 
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other. Although such research is intriguing, the small sample size, lack of differentiation 
among PD severity type, and use of questionably appropriate assessment devices (e.g., 
questions unable to be answered by PD patient due to cognitive impairment) limits this 
study's generalizability. Further, it is unclear as to whether caregivers were informed to 
fill out particular measures with answers regarding themselves, or their interpretation of 
how the patient would respond to such an item. Regardless, it is apparent that 
acquisition of information on the factors that may affect caregiver and patient 
participant's ability to adjust to a chronic is disease state is an area demanding 
additional attention. Procurement of this information could facilitate more positive 
interactions between the patient-caregiver dyad, as well as increase the general 
adjustment process to the disease condition. 
Statement of Purpose 
Due to the progressive and deteriorating nature of PD across family interaction 
dimensions, and emotional and physical functioning, it is important to identify risk factors 
that contribute to negative adjustment to the disease condition. Thus, the purpose of 
the current study was: 1) to identify the type of coping responses predominantly used by 
patients and caregivers, 2) to identify the relationship between the coping strategies 
predominantly used by patients and his/her caregivers and their reported level of 
adjustment, and 3) to identify the relationships between level of uncertainty and the level 
of general adjustment and depression reported by the patient and his/her respective 
caregiver. It is believed that a thorough examination of the responses both within and 
between the patient and caregiver groups would provide information as to how these 
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individuals cope with stressful sitLJations in general, and whether one method of coping 
used by patients is correlated with decreased levels of adjustment reported by 
caregivers (and vice versa). The following hypotheses are made in conjunction with 
these investigations: 
1. Patients and their caregivers would utilize more emotion:.focused coping than 
problem-focused coping. Consistent with Folkman and Lazarus (1980), it is believed 
that patients would predominantly utilize coping strategies that alter their feelings 
regarding the stress resulting from their diagnosis (i.e., emotion-focused strategies), as 
the conditions inherent in this situation are considered unchangeable or uncontrollable. 
2. Individually analyzing caregiver and patient populations, those participants 
utilizing emotion-focused strategies would have poorer levels of adjustment (as 
measured by increased SCL-90-R scale scores), and increased levels of depression [as 
measured by the Inventory for Diagnosing Depression (100)] than those using a 
problem-focused approach. 
3. Caregivers and patients with higher levels of uncertainty would also report 
poorer overall adjustment (as measured by the SCL-90-R subscales and the GSI 
scores, and the 100). 
Exploratory analyses were also conducted to determine those factors which may 
influence the level of adjustment (as measured by the SCL-90-R GSI scores and the 
100 depression scores) reported for both patients and caregivers. Specifically, the 
ability to complete activities of daily living (ADLs), use of emotion/problem-focused 
coping strategies and the level of uncertainty (MUIS) were examined separately for both 
patient and caregiver participant groups to determine the degree to which these 
variables contributed to the prediction of GSI and depression. A zero-order correlation 
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was also conducted to determine if the Clinical Disability Scale (Hoehn & Yahr, 1967), 
which assesses the stage of disease progression, was related to either the GSI or 100. 
Additional exploratory analyses were performed to examine the relative influence of 
specific patient variables (i.e., level of adjustment, coping strategy used, level of 
uncertainty, level of depression) on caregivers reported level of global adjustment and 
depression. Identical analyses examining the relationship between caregiver variables 
(i.e., level of adjustment, coping strategy used, level of uncertainty, level of depression) 
and patient global adjustment and depression were also completed. 
· Method 
Participants 
Individuals who attended local PD support groups affiliated with the American 
Parkinson's Disease Association (APDA) were recruited to participate in the study. To 
be included, participants were determined to be a patient-caregiver dyad in which both 
members were willing to participate. All participants were asked to complete their 
questionnaires at home and return the packets via a self-addressed stamped envelope. 
A total of 44 patient-caregiver dyads (70%) returned completed protocols. 
The total patient participant sample was comprised of 31 males (71%) and 13 
females (29%), with a mean age of 72.8 (SD= 7.2) and a range of 49 to 88 years of 
age. The caregiver sample included 11 males (25%) and 32 females (73%: one 
caregiver did not complete all portions of the questionnaire), with an average age of 70 
(SD = 8.3) and an age range of 47 to 87. The mean age of the patient population at the 
time of diagnosis was 66 years (SD= 7.9). Thus, average duration of illness was 6.5 
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years (SD = 3.8). Ninety-one percent of the patient population and 93% of the caregiver 
population reported their marital status as married. Nine percent of the patient sample 
and sixteen percent of the caregiver population reported that they were currently 
employed. 
On the Hoehn and Yahr Clinical Disability rating scale, 39% of the patients were 
rated as "moderately" impaired with the remaining 59% being distributed across the 
"mild", "mild-moderate", "moderate-severe," and "severe" categories (22%, 17%, 19%, 
and 2%, respectively). Thus, 78% of the sample fell into the mild to moderate range of 
functioning. Average income for both the patient and caregiver samples was an 
estimated $30,000 to $40,000 annually per household; education level averaged 15 
years ( SD = 3) for the patient participants and 14 years ( SD= 2) for the caregivers. 
Ninety-six percent of the patient participants and eighty-six percent of the caregiver 
participants reported that they were currently attending a Parkinson's disease support 
group. Ninety-one percent of the dyads were classified as spousal relationships, five 
percent were parent-child relationships, and the remaining four percent were comprised 
of hired help or constituted missing data. No statistical differences were found across 
dependent measures based on the type of patient-caregiver relationship (husband-wife 
vs. parent-child; all Q values > .05). 
Measures 
Demographic Information. Following acquisition of a signed informed consent 
form for participation (see Appendix A), the first set of items provided to the subject 
contained questions pertaining to demographic information. Two separate demographic 
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forms (patient and caregiver versions) were used (see Appendix C and D; Appendix B is 
an informational sheet containing directions for the subject and potential referral sources 
if psychological services were warranted). 
Inventory for Diagnosing Depression {IDD). The Inventory for Diagnosing 
Depression (IDD; Zimmerman et al., 1986) was utilized as a general measure of 
emotional adjustment to the PD condition (see Appendix E). The IDD is a self-report 
inventory comprised of items designed to diagnose major depression and the severity of 
depressive symptomatology. The criteria delineated in the DSM-111-R (APA, 1987) was 
utilized to develop item inclusion on the IDD (diagnostic criteria did not change for the 
DSM-IV), resulting in applicability of scores to the diagnosis of clinical depression. The 
IDD is an internally consistent and reliable measure of depression-related symptoms 
and is significantly correlated with other depression inventories and with diagnoses 
based on clinical judgment (Goldston, O'Hara, & Schartz, 1992). 
Patient and caregiver IDD summary scores (with higher scores being associated 
with decreased adjustment) were used to examine the relationship between depressive 
symptomatology and specific variables including the MUIS, WOCL (both problem- and 
emotion focused), ADLs, and stage of PD rating scale (See Tables Ila and llb). The IDD 
was also utilized as a criterion variable in exploratory multiple regression analyses to 
determine the relationship between patient participant's depression and a variety of 
caregiver predictor variables (e.g., MUIS, GSI). Additional identical analyses were 
conducted to explore the relationship between caregiver participant's depression and a 
variety of patient participant variables. 
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Activities of Daily Living (ADU. The AOL measures used in the current study are 
revisions of the Instrumental Activities of Daily Living (IADL; Lawton & Brody, 1969), 
which was developed to measure functional ability (see Appendix F and G). Whereas 
the basic information assessed by each item was maintained, wording of the items on 
the revised versions was simplified in order to facilitate readability for participants. Two 
separate measures were developed with wording changes to individually target 
caregivers (e.g., "When using the phone, the individual with PO typically ... ") and patients 
with PO (e.g., "When using the phone,_!..."). Frequency data, with values between zero 
and two, were tabulated across items with zero representing mild to no impairment, and 
two indicating severe deficits in functional impairment. These measures provide 
information regarding the extent to which patient's ability to accomplish the tasks of daily 
living is effected by the physical manifestations of PD. The AOL measure was used in 
exploratory hierarchical multiple regression analyses to determine the relative influence 
of patient's ability to complete these tasks on both patient and caregiver participant level 
of adjustment (GSI) and symptoms of depression (100). 
Hoehn & Yahr Clinical Disability Rating Scale-Revised. The original Hoehn and 
Yahr (H-Y; 1967) measure of clinical disability is a self-report measure utilizing a five-
point rating system to categorize the stage of illness manifestation (see Appendix H). 
This measure was minimally modified for the current study so that caregivers could ad 
as informants regarding the patient's current level of disability. Although the criteria for 
each stage of disability was maintained, additional descriptions of criteria and examples 
of behaviors identifiable at each stage were provided in order to facilitate appropriate 
categorization of each patient. The rationale regarding the utilization of third party 
informants is two-fold; 1) physical self-assessment by individuals with PO has low 
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validity (Golbe & Pae, 1988), and 2) the measure is somewhat complex and time 
consuming, which may lead to undue frustration for the patient. Overall, it is believed 
that the observations made by the primary caregiver during the course of providing care 
are sufficient for accurate identification of a patient's current stage of disability. 
PD ratings were used to examine the relationship between severity of disability 
and variables assessing measures of adjustment (GSI, IDD), type of coping strategy 
utilized (problem- or emotion-focused), and level of uncertainty (MUIS). These analyses 
were exploratory in nature. 
Mishel Uncertainty in Illness Scale-Community Form (MUIS-CF). The MUIS-CF 
(Mishel, 1981) is a self-report instrument that measures subjective feelings of 
uncertainty in relation to five illness-related categories: 1) symptoms, 2) diagnosis, 3) 
treatment, 4) relationships with caregivers (patients), and 5) plans for the future (see 
Appendix I and J). Separate forms were developed for use with patients (23 items) and 
with caregivers (29 items). Normative data was compiled from eight samples of 
individuals with medical condition (e.g., cancer, Myocardial Infarction, Multiple Sclerosis). 
For this study, the 23 items that are identical in content but different pronouns were used 
{e.g., I feel that the doctors are doing their best for me, versus I feel that the doctors are 
doing their best for him/her). Participants rated each item on a five-point Likert scale 
ranging from 1 (strongly disagree) to 5 (strongly agree). Mishel's scoring system was 
used wherein point values for each item are totaled, resulting in a summary score for the 
measure with higher scores representative of higher uncertainty. The measure has 
been used extensively with chronically ill populations {Stetz, 1989; Webster & 
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Christman, 1988) to assess the influence of illness-related events. The MUIS has a 
moderate reliability estimate of .71 for the normative sample. For this study internal 
consistency was high for the caregiver participant sample (alpha = .82) and moderate for 
the patient sample (alpha= .63). 
Revised Ways of Coping Checklist (WOCL). The WOCL is a measure used to 
determine the specific coping strategies utilized by individuals to cope with a stressor 
that recently occurred in the participant's life. The WOCL was given to both patient and 
caregiver participants in the current study (see Appendix K). To maintain consistency 
with the basic purpose of this measure (Folkman & Lazarus, 1980), participants were 
asked to rate a general stressful situation experienced within the previous month rather 
than requesting information on a specific disease-related stressor. Previous research 
suggests that focusing on disease-specific rather than general stressors does not 
increase the amount of variance explained when examining the level of adjustment in 
medically involved participants (Beatty, 1993; Jean, 1996; Sanchez, 1996). Thus, how 
individuals cope with daily or general life stressors may be a better predictor of 
psychological adjustment than would information on how these individuals cope with 
disease-specific stressors. 
Based on this rationale, participants in this study were asked to provide 
information on a recent general stressful situation (e.g., location of the event, individuals 
involved, occurrences in the situation) and responded to questions assessing use of 
emotion- or problem-focused coping. Responses were recorded via a four-point Likert 
type scale with endpoints of "O", representing no use of a particular strategy, and "3" 
representing a strategy that is often employed (Folkman & Lazarus, 1988). 
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Eight different factors or subscales have been identified. Seven of these scales 
are described as emotion-focused (escape-avoidance, distancing, self-controlling, 
confrontative coping, accepting responsibility, positive reappraisal, and seeking social 
support) and one is described as problem-focused (planful problem-solving). To 
facilitate analyses, coping strategies were categorized as either emotion- or problem-
focused coping. Reliability information for the emotion- and problem-focused coping 
scales was high for both patient participants (alphas= .77 and, .83 respectively) and 
caregiver respondents (alphas = .89 and .91, respectively). 
Coping responses can be scored using both relative scores (percent of effort) 
and mean subscale scores (frequency count). Relative scores were utilized in the 
present study as they have been identified as presenting a more accurate reflection of 
individual coping differences (Vitaliano, Mauino, Russo, and Becker, 1987). Relative 
scores were obtained by dividing each mean subscale score (i.e., raw scores divided by 
the respective number of items on that scale) by the sum of the other mean subscale 
scores (including the numerator subscale). Relative scores were utilized for both the 
problem-focused and emotion-focused scales. 
Symptom Checklist-90-Revised {SCL-90-R). The SCL-90-R is a self-report 
inventory consisting of 90 items used to measure the emotional adjustment of both the 
patient participant and his/her caregiver to PD (see Appendix L). The SCL-90-R was 
designed to assess the presence of psychopathology in psychiatric and/or medical 
settings. The measure takes an average of 20 minutes to complete, has high internal 
consistency (.77-.90), high test-retest reliability (.78-.90), and has separate gender 
norms and norms for both community and psychiatric patients. Community norms were 
used for the purpose of the study. The SCL-90-R's nine clinical subscales that assess 
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psychological distress include: somatization (som), obsessive-compulsive symptoms 
(obs), interpersonal sensitivity (ins), depression (dep), anxiety (anx), phobic anxiety 
(pho), psychoticism (psy), paranoid ideation (par), and hostility (hos). The SCL-90-R also 
provides a composite index, the Global Severity Index (GSI), which is a combination 
measure of the intensity of perceived distress (PSDI), and the number of symptoms 
experienced. The GSI was used as the primary criterion variable in hierarchical multiple 
regression models assessing the influence of predictor variables on level of adjustment 
for both patient and caregiver participants. The GSI was also used as a predictor 
variable to determine it's influence on the level of depression reported by participants. 
Based on previous studies which have examined the psychosocial aspects of disease 
syndromes (Beatty, 1993; Dakof & Mendelsohn, 1986; Tate et al., 1993), the SCL-90-R 
GSI, Somatization, Depression, Anxiety, Obsession/Compulsion, Hostility, and 
Interpersonal Sensitivity subscales were also used as secondary dependent variables in 
the current study. 
The clinical significance of subscale score elevations can be assessed through 
examination of T-scores (i.e., M=50, SD=10) and via caseness (Derogatis & Spencer, 
1989). The caseness criterion for maladaption has been utilized to assess adaptation to 
chronic illness (Thompson, 1985: Thompson et al., 1992). Caseness is defined as a 
GSI score, or two or more subscale scores, equal to or greater than 63. 
Procedures 
The methods, participants and procedures used in this study were developed in 
accordance with American Psychological Association guidelines and were approved by 
Oklahoma State University's Institutional Review Board prior to its initiation. Subjects 
were recruited during the monthly APDA support group meetings held in three 
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metropolitan cities. Subjects were provided both verbal and written instructions for 
completing the questionnaire packet. In addition, each packet, which was marked to 
identify individual dyads, included the researchers' phone numbers for any questions 
that might arise while completing the packet at home. One dollar was donated to the 
National Parkinson's Disease Foundation for each completed packet. 
Two separate packets were provided for the patient-care provider dyads. Both 
packets included the following measures: the Symptom Checklist-90 Revised (SCL-90-
R; Derogatis & Spencer, 1989), the Inventory for Diagnosing Depression (100; 
Zimmerman et al., 1986), Mishel's Uncertainty in Illness Scale-Community form (MUIS-
CF; Mishel, 1981), and a demographic questionnaire. Packets also included separate 
caregiver and patient versions of the Ways of Coping Checklist (WOCL; Folkman & 
Lazarus, 1988). Caregiver packets also included a revised version of the Hoehn and 
Yahr clinical disability rating scale. 
Overview of Analyses 
The overall purpose of the current research was to identify the type of coping 
strategy predominantly utilized by individuals with PD and their caregivers, elucidate the 
relationship between patient and caregiver use of particular coping strategies and 
general adjustment and depression; and to examine the relationship between perceived 
level of uncertainty toward their chronic condition and overall adjustment. Psychological 
adjustment, as measured by the SCL-90-R GSI and the 100 scores, were used as the 
criterion variables, while the remaining variables (i.e., functional ability, coping strategy, 
level of uncertainty) were used as predictors of adjustment to the disease condition. To 
provide a context for interpretation of results, Derogatis and Spencer's (1989) criteria for 
caseness, a more stringent diagnostic criteria for the SCL-90-R, was also used to 
Parkinson's Disease 39 
determine the percentage of the current total sample evidencing psychological or 
emotional maladaption. IDD scores were also analyzed to determine the percentage of 
the caregiver and patient participants reporting symptoms consistent with DSM-IV 
criteria for diagnosis of Major Depression. Means and standard deviations for each of 
these measures by group can be found in Table 1. 
To examine hypothesis 1, relative coping scores were calculated for both the 
patient and the caregiver groups to determine the type of coping strategy predominantly 
employed by members of each group. For hypothesis 2, which targeted use of emotion-
focused coping and its association with level of overall adjustment, zero order 
correlations were performed to examine the relationship between SCL-90-R T-scores, 
IDD scores, and emotion-focused coping. To examine the relationship between level of 
uncertainty (MUIS) and overall adjustment (Hypothesis 3), zero order correlations were 
conducted on MUIS scores and variables assessing adjustment level (SCL-90-R 
subscale and GSI scores, and the IDD). 
Due to the potential for shared variance between demographic, functional ability, 
coping strategies utilized and adjustment, exploratory hierarchical multiple regressions 
were also conducted in order to examine the relative contribution of these factors to 
adjustment of both patients and car-egivers. Thompson's Transactional Stress and 
Coping Model (Thompson et al., 1992; Thompson et al., 1994), which is based on 
Folkman and Lazarus' model of coping and adaptation, was employed as a guide for 
variable selection and order of entry. This model utilizes a multivariate conceptual 
framework that identifies chronic illness as a stressor to which the individual and his/her 
associated systems (e.g., caregivers) attempt to adapt. Thompson's model incorporates 
a variety of factors (e.g., disease parameters, demographics) believed to influence the 
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adjustment outcome of individuals and has been used in various other studies 
examining adjustment to chronic illness (Thompson et al., 1994). · Thus, this model was 
used to determine the unique variance contributed by variables believed to mediate the 
illness-outcome relationship above and beyond the contribution of illness and 
demographic parameters. Based on this theoretical framework, GSI and IDD scores 
were used as the criterion variables. For patient and caregiver groups, separate models 
were constructed with simultaneous entry of age and gender first, followed by functional 
ability (AOL), coping strategy (emotion- or problem-focused), step 4 represented level of 
perceived uncertainty, and lastly, an interaction variable of MUIS and the coping strategy 
entered in step 3. 
Additional analyses were conducted to explore the influence of caregiver 
participant use of emotion- or problem-focused coping and level of uncertainty on patient 
adjustment using the GSI and IDD as separate criterion variables. An identical 
regression model was constructed to determine if patient scores on these measures 
contributed to the prediction of caregiver GSI and/or IDD. 
Results 
Preliminary Analyses 
A series of preliminary analyses were first performed to examine the effects of 
the patient's gender and employment status on all primary measures. A 2 X 2 (gender x 
employment status) multivariate analysis of variance revealed no main effects or 
interactions for the SCL-90-R Global Index Score (GSI), the IDD, the MUIS, or the 
WOCL (both problem- and emotion-focused strategies; all Q values > .05). An 
identical Manova examining caregiver gender and employment status revealed no main 
or interaction effects on the aforementioned measures {all Q values > .05). A Manova 
Parkinson's Disease 41 
was also performed to examine patient-caregiver relationships on all dependent 
measures. This procedure allowed for the examination of all main effects and possible 
interactions among interrelated dependent measures. Analysis of data in this study 
demonstrated no main effects or interactions among the patient and caregiver 
dependent measures (all Q values> .05). An additional Manova was performed to 
I 
determine if differences on the dependent measures occurred due to the type of dyads 
utilized in this study (marital versus parent-child or hired help). No significant main 
effects or interactions occurred among these dyads on these measures. 
T-scores for patient participants on the SCL-90-R scales of Depression, Anxiety, 
Somatization, Obsessive-compulsiveness, and GSI, were all at least one standard 
deviation above the normative group mean of 50. On the MUIS, the patient participant 
mean score was one standard deviation above the normative sample. 
For the caregiver participant sample, the means for each SCL-90-R subscale 
were all within one standard deviation of the normative mean. For the MUIS, the 
caregiver participant group's mean score was at least one standard deviation above the 
normative group mean. The IDD mean summary score for the caregiver participant 
group was not clinically significant. 
The data was then further examined to ascertain level of adjustment as 
measured by the SCL-90-R and IDD. Using Derogatis and Spencer's (1989) criteria for 
caseness, 77% of the patient population (n=33) and 30% of the caregiver population 
(n=12) evidenced significant levels of maladaption as defined by caseness. Further, 
eighteen percent of the patient participants, and five percent of the caregiver participants 
met DSM-IV criteria for diagnosis of Major Depression based on their IDD scores. 
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Zero-order correlations were then computed for the SCL-90-R scale scores, 100 
scores, emotion- and problem-focused coping strategies, age, functional ability (ADLs), 
disability ratings, and uncertainty for the patient (see Table Ila) and caregiver 
participants (see Table lib). For the patient participant sample, the depression subscale 
of the SCL-90-R was significantly positively correlated with PD disability rating ( Q < 
.001) and functional ability ( Q < .01). 100 summary scores for the patient participants 
were significantly positively correlated with level of uncertainty [{MUIS), Q < .05] and 
functional ability [(AOL), Q < .01). The AOL was also significantly positively correlated 
with the Global Severity Index subscale (GSI) of the SCL-90-R. 
Caregivers' age was negatively correlated with the SCL-90-R depression scale 
( Q < .05), anxiety scale ( Q < .05), somatization scale ( Q < .01), hostility scale (Q < .01), 
obsessive/compulsiveness scale (Q <.01 ), and the GSI scale ( Q < .01; See Table lib). 
Caregiver participants scores on the MUIS were significantly positively correlated with 
the SCL-90-R depression subscale ( Q < .05), anxiety subscale ( Q < .05), and the GSI 
subscale { Q < .05), and the 100 ( Q < .01). Caregiver participant's report on the 
1patient's functional ability and the stage at which they are functioning did not significantly 
correlate with any of the SCL-90-R subscales or the 100 summary score. 
Correlations were then conducted between patient and caregiver variables {See 
Table lie). Significant correlations emerged between patient and caregiver MUIS { Q < 
.005) and 100 ( Q < .05) scores, and patient participant's 100 summary score and both 
the caregiver participant's SCL-90-R depression subscale score ( Q = .05) and reported 
level of uncertainty { Q < .05). No other significant correlations were noted between the 
participant groups on the dependent measures (i.e., MUIS and SCL-90-R subscale Q 
values > .05). 
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Research Question 1: Type of coping style used by patient and caregiver participants 
Examining the patient and caregiver groups separately, patient participants 
reported using relatively more problem-focused coping (52%) than emotion-focused 
coping (48%). Differences also occurred between caregiver's use of coping strategies 
(problem-focused: 57%; emotion-focused: 43%). Whereas patient and caregiver 
participant's use of more problem-focused than emotion-focused coping strategies was 
contrary to prediction, these percentages, while statistically significant are not believed to 
be clinically. 
Research Question 2: Relationship between coping style and psychological adjustment. 
For patient participants, emotion-focused coping was significantly correlated with 
increased scores on the SCL-90-R scales of depression, anxiety, 
obsessive/compulsiveness, and hostility, as well as the global measure of adjustment, 
the GSI (See Table Ila). Emotion-focused coping was also significantly and positively 
correlated with IDD scores. Notably, there was an inverse correlation between use of 
problem-focused coping and scores on the hostility and depression scales of the SCL-
90-R. Consistent with hypothesis 2, the results indicate that use of emotion-focused 
coping was related to lower levels or poorer overall adjustment, while use of problem-
focused coping was related to higher levels or better adjustment. 
For caregivers, due to the significant correlation between age and level of GSI, 
semi-partial correlations were utilized to control for the effects of this variable on the 
remaining primary measures. Results of this analysis indicated that caregiver 
participants' utilization of emotion-focused coping was significantly and positively 
correlated with all subscales of the SCL-90-R, except the somatization scale (See Table 
llb). A significant positive correlation was also found between use of emotion-focused 
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coping and IDD summary score. Consistent with patient participant results, use of 
emotion-focused coping by caregiver participants was related to poorer overall 
adjustment and higher levels of depression. In contrast, caregiver participants' use of 
problem-focused coping was also related to increased levels of depression and hostility 
as measured by the SCL-90-R depression and hostility subscales. This relationship did 
not emerge between problem-focused coping and the IDD, which is a more stringent 
measure of depressive symptomatology. 
Research Question #3: Relationship between level of Uncertainty and Adjustment 
Zero-order correlations were computed for patient and caregiver participants on 
the MUIS and all scales of the SCL-90-R and the IDD summary score (See Tables Ila 
and lib). Patient participants' MUIS scores were not significantly correlated with any of 
the SCL-90-R subscales or GSI scores (all Q values > .05), but were significantly 
correlated to the 100 summary score ( Q < .05; See Table Ila). For caregiver 
participants, MUIS scores were significantly correlated with the SCL-90-R Depression ( 
Q < .05), Anxiety ( Q < .05), and GSI ( Q < .05) subscales and the IDD summary score ( 
Q < .05). 
Overall, bivarate and semi-partial correlations were used to analyze three 
separate questions associated with patient participants with PD and their caregivers. 
Contrary to hypothesis 1, both the patient and caregiver participants reported using 
relatively more problem-focused coping than emotion-focused coping. Results largely 
supported hypothesis 2, which stated that use of emotion-focused coping would be 
associated with decreased levels of adjustment for both patient and caregiver 
participants. Partial support was also found for hypothesis 3, which concerned the 
relationship between increased uncertainty and poorer overall adjustment for caregiver 
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participants and increased uncertainty and increased depressive symptomatology for 
patients. To better understand the relationships between the constructs examined in 




Exploratory hierarchical multiple regression analyses were then performed on the 
patient and caregiver data to examine the relative contribution of demographic variables 
(gender, age), functional ability (ADLs), coping strategy, and uncertainty to the prediction 
of general adjustment (GSI scores) and depression (IDD scores). The Hoehn and Yahr 
(1967) Clinical Disability Scale (used to assess stage of disease progression) was not 
incorporated into the models as this instrument did not significantly correlate with the 
GSI scale or the IDD summary score for either the patient or caregiver participant 
samples. Thompson's (1985) Transactional Stress and Coping model was used to 
· guide the entry of the variables into the model. For each equation, demographic data 
was entered simultaneously on the first step (age, gender), followed by functional ability, 
and then entry of emotion-focused or problem-focused coping (in separate models). 
Uncertainty scores were then entered on step 4 of each equation, followed by 
subsequent entry of an interaction variable comprised of a MUIS total score and 
emotion-focused coping (or MUIS total score and problem-focused coping; See Tables 
Ill-VI), Thus, the regression analyses were hierarchical between sets and stepwise 
within sets (Cohen & Cohen, 1983). 
A stepwise multiple regression analyses was conducted using demographic 
' 
variables (i.e., age, gender), functional ability, level of uncertainty, and use of emotion- or 
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problem-focused coping strategies to predict level of general adjustment (GSI score). 
For the patient population, results revealed that age and gender (step 1) and functional 
ability (AOL) significantly contributed to the prediction of global adjustment (See Table 
Ill). In equation 1 of this model, after controlling for steps 1 (age and gender) and 2 
(functional ability), the remaining variables [problem-focused coping, level of uncertainty 
(MUIS), and the combined interaction variable of MUIS and problem-focused coping] did 
not contribute significant variance to the GSI. In equation 2, however, after controlling 
for the demographics variables and for functional ability, emotion-focused coping was 
found to be a significant predictor of global adjustment on the GSI ( Q <.005). The 
MUIS variable (step 4) and the interaction variable of MUIS and emotion-focused coping 
were not significant. 
For the caregiver population, after controlling for demographic parameters, 
functional ability, and use of problem-focused coping (all Q values> .05), only the 
MUIS variable contributed significant unique variance to the prediction of GSI in equation 
1 (See Table IV). In equation 2, after controlling for the demographic variables and 
functional ability (ADLs), both the emotion-focused coping variable (step 3) and the 
MUIS variable (step 4) significantly contributed to the prediction of the GSI. There were 
no interaction effects obtained between the MUIS and the individual coping strategies in 
either equation 1 or 2 of this model. 
Hierarchical multiple regressions were also performed to examine the relative 
contribution of demographic parameters (age and gender), functional ability, coping 
strategies, and uncertainty to depressive symptoms as measured by the 100 (See 
Tables V and VI). Separate patient and caregiver models were developed, each 
beginning with simultaneous entry of age and gender, followed by functional ability 
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summary score, and individual entry of emotion- or problem-focused coping. 
Uncertainty was entered on step 4, followed by an interaction term of uncertainty and 
one of the coping strategies on 
step 5. 
For patients, after controlling for demographic parameters, a significant main 
effect emerged between functional ability and depressive symptomatology as measured 
by the 100 (See Table V). No other main effects were found for the remaining variables 
in equation 1 of this model (problem-focused coping, MUIS, and the interaction variable 
of MUIS and problem-focused coping) and the 100. In equation 2, after controlling for 
demographic variables and functional ability on step 1 and 2, emotion-focused coping 
significantly contributed to the prediction of depressive symptoms as measured by the 
100 (See Table V). No effects were found for either the MUIS variable or the interaction 
variable of MUIS and emotion-focused coping on depressive symptomatology in 
equation 2. 
Results for identical analyses with the caregiver participants demonstrated that 
after controlling for demographics and functional ability, steps 3, 4, and 5 of equation 2 
(i.e., emotion-focused coping, MUIS, and the interaction variable of the MUIS and 
emotion-focused coping) all significantly contributed to the prediction of 100. This 
suggests that individuals who may be experiencing higher levels of uncertainty may 
resort to more emotion-focused coping strategies which may result in higher levels of 
depressive symptomatology. 
Finally, additional exploratory hierarchical multiple regression analyses were 
performed to examine the relative contribution of caregiver participant variables (GSI, 
emotion/problem-focused coping, level of uncertainty) to the prediction of patient 
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participant's level of adjustment (GSI; See Table VII). No significant main effects 
emerged (all Q values> .05). Analyses were also conducted to determine the 
contribution of the patient participants' variables (GSI, coping strategy and uncertainty) 
to the prediction of caregiver participants' GSI (See Table VIII). In this model, a 
significant main effect emerged for patient use of problem-focused coping and caregiver 
GSI scores. 
Discussion 
The purpose of the present study was to identify the type of coping style 
predominantly used by patient and caregiver participants, and to determine the 
relationship between both the type of coping strategies used, and the level of uncertainty 
on overall level of adjustment (GSI and depression) of participants with PD and their 
caregivers. Primary predictors of overall level of adjustment used in this study included 
functional ability, emotion- and problem-focused coping strategies, and level of 
uncertainty. More specifically, the study focused on determining if patient participants 
with PD and their caregivers predominantly use one type of coping strategy, whether 
use of one type of coping strategy was associated with problems of adjustment, and if 
the inclusion of the level of uncertainty experienced by the participant was also 
significantly related to adjustment (i.e., GSI, 100). 
Based on the assumption that chronic medical conditions involve various 
demands and stressors that are perceived as unchangeable or uncontrollable (e.g., 
physical degradation, progressive deterioration), it was hypothesized that individuals with 
PD would more often utilize coping strategies that involve affect (i.e., emotion-focused), 
rather than ones geared toward modifying the situation (i.e., problem-focused) which 
may appear to be ineffective given the circumstances of the disease state. Counter to 
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predictions and previous research on individuals with chronic medical conditions (Billings 
& Moos, 1981; Campas et al., 1996; Folkman & Lazarus, 1980), participants with PD 
utilized significantly more problem-focused coping than emotion-focused strategies. 
Such results may be due in part to the unique characteristics of individuals involved in 
chronic disease support groups. These individuals may represent a subset of the PD 
population that is more actively confrontive in their approach to addressing the problems 
that arise with the PD condition. The underlying goal of these support groups is the 
dispersion of information on how best to manage the PD condition, which in and of itself 
defines use of problem-focused coping. Thus, patients may actively engage in 
behaviors suggested by their peers as being helpful in the management of their disease 
(e.g., mix your medication with ginger ale in the morning and you will avoid the 
symptoms of nausea typically experienced when taking this pill alone). Although 
speculative, it may also be that patients' increased use of problem-focused coping is a 
result of their compliance with caregiver suggestions/aide regarding management of 
disease related tasks. 
Also contrary to prediction and previous literature (e.g., Pratt, Schmal!, Wright, 
Cleland, 1985), it was found that caregiver participants' predominately used problem-
focused coping versus emotion-focused coping. Again, it may well be that the reported 
use of more problem-focused methods may be inherently related to the task of providing 
direct care to the patient More specifically, the intrinsic role of the caregiver is to 
attenuate the difficulties experienced by the patient (e.g., facilitating the accomplishment 
of daily tasks for the patient) which demands the use of active problem-solving 
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strategies (e.g., needing to install rails in the shower to facilitate bathing). Thus, the 
relatively higher use of active strategies by caregiver participants may be functional in 
that some day-to-day difficulties can be managed through use of active problem-solving 
strategies. 
Consistent with other investigations of individuals with chronic medical conditions 
(Cummings, 1993; Ehmann et al., 1990; Larson, 1978; Palmore & Likert, 1972), 
individuals with PD appear to be at significant risk for experiencing increased levels of 
both general and specific distress as compared to healthy counterparts. In comparison 
to community norms, the current results indicate that individuals with PD evidence 
higher levels of distress as measured by examination of SCL-90-R scale scores and the 
IDD. Patient participants in this sample reported significantly higher levels of 
depression, anxiety, obsessive/compulsiveness, somatization and Global Symptom 
Severity (as measured by the GSI) in comparison to available norms. Of particular note 
is the disproportionately high percentage of patient participants (77%) meeting the SCL-
90-R caseness criteria. This finding is important as it indicates that individuals in the 
patient participant group are experiencing significant difficulty in adapting to their chronic 
illness (Thompson, 1985: Thompson et al., 1992) that is not being "picked up" by more 
specific measures of maladaption such as the 100. Thus, these individuals appear to be 
experiencing significant difficulties in mood across a variety general indices that, while 
not clinically diagnosable in any one area, combined may contribute to significant 
difficulties in overall adjustment. 
Assessment of depressive symptoms (IDD) in the patient participants suggested 
that approximately 18% of this sample reported symptoms indicative of a Major 
Depressive Disorder. Previous research on depression in older adults found that 
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approximately 3% of older adults presenting in a medical setting (Koenig & Blazer, 
1992), and 3% of individuals in a community setting (Blazer et al., 1997) present with 
symptoms that can be diagnosed as Major Depressive Disorder. It was also found that 
stage of disease progression (Hoehn & Yahr, 1967) and decreased functional ability 
(measured by the AOL) were significantly correlated with the depression subscale of the 
SCL-90-R. These results indicate that as the disease progresses and affects more 
facets of the patient's physical functioning, their emotional functioning is placed in higher 
jeopardy as well. 
Whereas the 5% of the caregiver participants reported symptoms that would 
warrant a diagnosis of Major Depression, when individually examining the severity of 
summary scores on the 100, a large proportion of these scores were elevated (50%). 
· Further, 30% of this participant group met the SCL-90-R caseness criteria which 
suggests they are experiencing a heightened difficulty in adjusting the disease condition. 
These findings are consistent with those of Shelly and Quittner (1998) who found that 
levels of depression increased in caregivers as the demanding and often 
unpleasantness of the tasks inherent in providing care to a chronically ill individual 
increased. In addition, research by Williamson, Shaffer, and Shelly (1998) suggests that 
caregivers' affect increases after having "helped" the person for which they provide care. 
As hypothesized, patient use of emotion-focused coping strategies was 
significantly correlated with increased scores on the 100 which suggests a presence of a 
marked inability to cope with the stress associated with the chronic disease state. Also 
as predicted, use of emotion-focused coping by the patient participants was significantly 
correlated with increased SCL-90-R scores for depression, anxiety, hostility 
obsessive/compulsiveness, and global severity subscales. It is speculated that 
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individuals with PD, like individuals with other disease conditions (Folkman & Lazarus, 
1988; Lazarus, 1993), who may be feeling overwhelmed or hopeless may "give up" on 
taking active steps to make changes in their overall situation. More specifically, rather 
than identifying ways to decrease the effects of the condition, they may be focusing on 
the negative aspects of their disease which ultimately affects mood, or may be so riddled 
with symptoms of the condition (either directly or indirectly) that they are unable to take 
active steps to lessen the disease's affects on functioning in daily life. Whereas 
problem-focused coping may utilized more frequently by this sample, the relationship is 
evident that for those who resort to more emotion-based strategies, higher level of 
distress are noted. 
Similar findings resulted for the caregiver population. Caregiver participant's use 
of emotion-focused coping was significantly correlated with increased 100 summary 
scores and SCL-90-R scores on the depression, anxiety, hostility, 
obsessive/compulsiveness, and overall global severity (GSI) subscales. It is speculated 
caregiver participants may resort to more emotion-focused coping strategies when 
problem-focused methods appear futile in the attempt to manage the affects of the 
patient's impending degradation on daily life events. 
Of importance is the significant level of uncertainty reported the patient 
population in the current study. Means on the MUIS for the patient participants in this 
sample were much higher (x = 71) than those reported by Mishel (1990) for individuals 
with other general medical conditions, such as Myocardial Infarctions (x = 49), Coronary 
Artery Bypass (x = 60) and Multiple Sclerosis (x = 63). For patient participants in this 
study, increased levels of uncertainty was also significantly related to higher 100 
summary scores. Based on this finding, it is speculated that increased levels of 
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uncertainty about a disease (e.g., lack of knowledge regarding various facets of the 
chronic condition such as trajectory of degradation, time-line of disease progression) 
may have an adverse affect on the level of depressive symptomatology experienced by 
the individual diagnosed with the condition. Whereas a significant positive correlation 
emerged between patient participant's level of uncertainty and depressive 
symptomatology, the MUIS did not correlated with any other dependent measure in this 
study for this participant group. These findings may be due in part to the functional 
status of those participating in this study. Participants in this study were largely 
represented in the advancing stages of PD and, thus, it is surmised that their ability to 
anticipate impending physical degradation and disease progress may have been 
hampered. More specifically, assessment of uncertainty in these individuals may not be 
appropriate as they are less able to foresee changes in their health status or may no 
longer be cognizant of the possible course of their disease. 
The MUIS appears to be a more salient predictor of adjustment for the caregiver 
participants in this study. For caregivers, increased scores on the MUIS was signficantly 
positively correlated with poorer general adjustment (GSI), and increased scores on the 
IDD and the SCL-90-R depression and anxiety subscales. Further, the MUIS was a 
significant predictor of general adjustment and depressive symptomatology above and 
beyond the effects of the coping strategy used or the patient's level of functional ability. 
It is postulated that caregivers may be significantly negatively affected by the uncertainty 
of disease manifestation, as increased symptomatology represents additional caretaking 
responsibilities. Logically, the addition of new caretaking obligations may result in the 
development of negative mood-related symptoms and lead to poorer overall adjustment. 
Thus, the level of uncertainty encountered by both individuals directly (patient) 
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and indirectly (caregiver) affected by the PD condition appears to be quite important in 
relation to their resultant emotional adjustment. The current findings may suggest that a 
general lack of information concerning the disease itself, and details regarding the 
anticipated progression of disease symptoms, may leave the patient and his/her 
caregiver more vulnerable to increased distress. Thus, appropriate dissemination of 
information regarding the general aspects of the disease and issues/symptoms to 
anticipate arising may potentially effect the severity of distress encountered. At the 
same time, it may well be that patients and caregivers may have adequate information 
about the disease, but still feel uncertain. In this regard, future research will need to 
ascertain the relationship between knowledge and uncertainty. 
Exploratory analyses provided information as to additional variables that affect 
the level of overall adjustment for the patient population. It was demonstrated that age, 
gender, functional ability (AOL) and use of emotion-focused coping were all significantly 
associated with decreased adjustment and higher levels of depressive symptomatology. 
Logically, as people's age increases, the ability to complete the tasks of daily living 
becomes more difficult to complete due to natural physical changes that impede 
flexibility and mobility. Shelly and Quittner (1998) found that while only 4% of non-
institutionalized individuals under the age of 55 require additional aide with 
accomplishing personal needs, this rate increases dramatically for individuals over 55 
years of age. For this patient population, it is believed that the natural physical changes 
that occur may be perceived as advancing disease which, in this study, appears to have 
a deleterious affect on mood. It is surmised that patients experiencing impairment in 
their ability to complete the Activities of Daily Living (ADLs) may experience symptoms of 
the Learned Helplessness Phenomenon. More specifically, these individuals may enter 
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a downward spiral of physical and emotional degradation: as their physical health 
decreases, their ability to complete the tasks of daily living may become compromised 
which may lead to feelings of hopelessness/helplessness. With several unsuccessful 
attempts to complete these tasks, they may lose confidence about their functional ability, 
and may ultimately give up on trying to accomplish these tasks all together. As a result 
of these changes in mood state, patient's may become less able to take a more active, 
f?roblem-solving approach to coping and may resort to using more emotion-focused 
methods. 
Examination the caregiver participant data indicates that the patient's functional 
ability, and the caregivers reported use of emotion-focused coping and level of 
uncertainty all contribute to the prediction of adjustment and depressive symptomatology 
in the caregiver participant sample. Such results suggest that caregivers providing care 
for individuals with decreased functional ability, under conditions of high uncertainty, tend 
to utilize coping strategies that are emotion-focused. It may be that providing these 
caregivers with techniques to both manage daily stressors associated with caring for an 
individual with a chronic disease and decreasing uncertainty, could change the type of 
coping strategy used, thereby enhancing their mood and ultimately their overall level of 
adjustment. This belief is supported by research conducted by Williams, Shaffer, and 
Shelly (1998) who found that caregivers reported higher levels of affect subsequent to 
providing aid that appeared to benefit the patient (e.g., changing the patient's position in 
bed and having the patient state they feel much more comfortable). Based on the 
information from the current study, caregivers who use emotion-focused coping (less 
direct, problem solving approach to patient care) may not receive this "positive" feeling 
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as they may not be engaging in caregiving behaviors that result in ostensible, immediate 
(or long-term) benefrt to the patient (e.g., scheduling a time for a bath rather than 
breaking down the steps needed to complete the task). 
Lastly, the reciprocal influence of patient and caregiver variables on overall 
adjustment was examined. Surprisingly, the only significant correlation occurred 
between patient use of problem-focused coping and decreased caregiver adjustment. 
Such a relationship may have resulted from "head-strong" patients who attempt to 
manage their own condition, which may run counter to the strategies attempted by the 
caregiver (e.g., the caregiver believes one particular standing sequence is appropriate 
while the patient vehemently uses his own method to stand from a seated position). 
Whereas it is apparent that the physical and emotional state of each member of the 
dyad has an effect on the other (e.g., zero-order correlations for patient and caregiver 
participant's MUIS ( Q < .05) and 100 ( Q < .05)], the underlying mechanisms of 
interaction between these patient and caregiver variables are unknown. Additional 
research in this areas is warranted as it would provide more specific information about 
complex patient-caregiver dyad relationships that could facilitate the development of 
interventions targeting adjustment to the disease condition. 
Several limitations are recognized within the current study. First, all participants 
utilized in this study were obtained from PD support groups. Individuals who seek/obtain 
help from support groups may possess characteristics/variables that are intrinsically 
different than non-participatory patients with PD and their caregivers. More specifically, 
the results of this study may reflect the type of coping strategies used, and levels of 
uncertainty and adjustment of individuals who seek self-help. To obtain a less biased 
participant sample, it is suggested that future studies include patients and caregivers 
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obtained from sites independent from PD support groups (e.g., physicians specializing in 
geriatric medicine, geriatric day care facilities). An additional limitation of the current 
participant groups in the inclusionary criteria of a patient-caregiver dyad. In this sample, 
over 90% of these dyads reported their relationship as marital in nature. Consequently, 
the participants may represent a subset of the PD population that present with 
differential characteristics specific to the marital relationship. Thus, their marital 
satisfaction and/or the marital relationship they had prior to PD diagnosis may 
significantly impact how these individuals have adjusted to the disease condition. 
Individuals who do not have a spousal caregiver may have less support/nurturance and 
thus may react differently to the disease process. 
A second limitation of this study is the use of self-report measures. Use of this 
form of data collection can result in a variety of method variance problems (e.g., high 
inter-item correlations). In order to decrease the potential for this to occur, future studies 
would benefit from incorporating a variety of independent measurement modalities (e.g., 
structured interviews, chart review, physical ratings). Further, the financial status (the 
majority of participants in the current study would be considered middle class with 
minimal financial strain) and education level of this study's participants limits it's 
generalizability. Recruiting patient participants from a variety of SES backgrounds would 
minimize this.limiting factor. 
An additional limitation of this study was the failure to include a "normal" control 
group. Obtaining information on individuals with similar demographics (age, education, 
financial status) could increase support for the significant results found in this study. 
Without information from a normal control, we cannot be certain that the results obtained 
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are truly "significant" and related to the variable targeted in this study (PD), or merely 
what may be considered "normal" for age-matched individuals with similar background 
characteristics. 
Several suggestions are made for future research with this population. An 
examination of the relationship between use of PD specific medications (e.g., types, 
doses, times taken) currently being used by patient participants and both mood and the 
ability to complete ADLs could provide information on more efficacious treatment 
approaches. With the advent of more advanced medical treatments (e.g., gamma knife) 
and pharmacological agents, more research is warranted to better predict positive 
treatment outcomes (e.g., increased adjustment) and to anticipate potential negative 
treatment outcomes. 
To more closely examine the relationship between use of particular coping 
strategies and adjustment to PD, it is suggested that researchers request information on 
two types of situations requiring the use of coping strategies. One situation should 
involve disease-related stressors, while the other situation would contain a more 
general, daily life stressors. This would allow for the acquisition of information on how 
coping strategies may change in response to the type of stressor for which they are 
used, or how individuals tend to resort to using the same type of coping strategy 
regardless of the situation at hand. Information. of this sort could be used to determine if 
individuals with rigid coping repertoires (i.e., use the same type of coping strategy 
regardless of the stressor) or with a more flexible approach to coping have better overall 
adjustment to the disease process. 
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Lastly, it would behoove future researchers to gather information on specific 
stressors and task demands experienced by both patients and caregivers that have 
been minimally examined in empirical studies. During the acquisition of the data for this 
study, several topics of concern were routinely broached by both patients and caregivers 
across the various supports groups attended by this researcher. These issues include 
the development of severe sleep disturbance (most commonly symptoms indicative of 
REM behavioral disinhibition) subsequent to ingestion of particular medications used to 
treat PD, possible interactions of PD medications with over the counter drugs (e.g., 
antihistamines), changes in personality, and interest in sex. Addressing these 
questions may dramatically improve the general coping and adjustment for both the 
patient and caregivers as these issues may dramatically impact the daily functioning of 
these individuals. 
In conclusion, while this study has provided useful information as to how 
individuals with PD attempt to cope with their chronic condition, it is apparent that the 
accumulation of information in this area is in it's infancy. Although gains are being made 
in understanding the broad reaching effects of the diagnosis of PD on both patients and 
caregivers, a critical link is missing in the conversion of the information obtained by 
researchers and the dissemination of this knowledge to those who would benefit most. 
Ideally, rather than merely identifying the symptoms and mechanisms of PD, future 
research in this area should address intervention efforts for individuals directly and 
indirectly affected by the disease with the hopes to ameliorate the struggles occurring in 
their daily life. 
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Table I. Means and Standard Deviations for All Dependent Measures 
I Patient Caregiver I 
SCL-90-R 
Global Index Score 66.8* 8.96 55.0 
Somatization 64.7* 10.7 51.5 
Depression 67.2* 9.10 56.4 
Anxiety 65.3* 10.6 53.2 
Obs/Comp 68.8* 9.90 57.6 
Hostility 52.1 11.3 50.7 
MUIS 70.6* 11.5 67.3* 
WOCL-PF 40.7 7.48 41.2 
WOCL-EF 52.4 10.0 44.2 
100 17.4 0.09 8.71 
* Indicates at least one standard deviation above the mean 
SCL-90-R = Symptom Checklist, 90 items, revised 
MUIS = Mischel's Uncertainty in Illness Scale 
WOCL-PF = Ways of Coping Checklist, Problem-focused 
WOCL-EF = Ways of Coping Checklist, Emotion-focused 
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T bl II C a e a. orre lati Pti tPrf" ts D onsfor a en a 1c1pan on epen 
WOCL· WOCL- MUIS AGE AOL 
PF EM 
SCL-90-R 
GSI -.26 .49**** .14 -.16 .33* 
So mat. -.17 .19 -.09 -.08 .16 
Depress. -.31-* .35-* .21 -.07 .43-
Anxiety -.26 .36*** .20 -.21 .26 
Ob/Com -.18 • .47- .17 .21 .38* 
Hostility -.32-* .21-* .13 .24 .23 
IDDSum. -.21 .39* .17* -.003 .53-
Score 
*.Q < .05, **.Q < .01, **.Q < .005, *-.Q < .001, ****.Q < .0005. 
GSI = Global Severity Index 
Somat. = Somatization subscale 
Depress. = Depression subscale 
Ob/Com = Obsessive/Compulsive subscale 
100 Sum. = Inventory for Diagnosing Depression 
WOCL-PF = Ways of Coping, Problem-focused 
WOCL-EM = Ways of Coping, Emotion-focused 
MUIS = Mishel's Uncertainty in Illness Scale 
· AOL = Activities of Daily Living Scale 
PD Rating = Hoehn and Yahr's Stage of Disability Scale 
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T bl llb C a e . If orre a ions t C or areg1ver Prf. ts a 1c1pan on D epen 
WOCL- WOCL- MUIS AGE AOL 
PF EM 
SCL-90-R 
GSI .23 .55***** .33* -.36* -.16 
Somat. .14 .22 .13 -.45** -.14 
Depress. .41*** .72***** .35* -.33* -.04 
Anxiety .12 .35* .33* -.27* -.26 
Ob/Com .24 .54***** .23 -.52** -.21 
Hostility .28* .47**** .07 -.50** -.03 
IDDSum. .09 .49**** .40** -.12 .07 
Score 
*Q < .05, **Q < .01, ***Q < .005, ****Q < .001, *****Q < .0005 
GSI = Global Severity Index 
Somat. = Somatization subscale 
Depress. = Depression subscale 
Ob/Com = Obsessive/Compulsive subscale 
IDD Sum. = Inventory for Diagnosing Depression 
WOCL-PF = Ways of Coping, Problem-focused 
WOCL-EM = Ways of Coping, Emotion-focused 
MUIS =.Mishel's Uncertainty in Illness Scale 
AOL = Activities of Daily Living Scale 
PD Rating = Hoehn and Yahr's Stage of Disability Scale 
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Table lie. Correlations for all Participants on Dependent Measures 
Patient Variables 
Age Gender MUIS 100 
Caregiver 
Variables: 
Age .70*** .04 .28* .09 
Gender .14 .78*** -.06 -.04 
MUIS .30* .03 .57** .30* 
100 -.09 .02 .20 .29* 
SCL-Dep -.24 -.05 .23 .27* 
SCL-Anx -.26 .08 .23 .02 
·SCL-Som -.39** .04 .0.6 -.11 
SCL-Hos .05 .12 -.04 .24 
SCL-GSI -.16 -.04 .16 .14 
*p < .05, **p < .01, ***p < .005 
MUIS = Mishel's Uncertainty in Illness Scale 
100 = Inventory for Diagnosing Depression 
SCL-Dep = SCL-90-R Depression Subscale 
SCL-Anx = SCL-90-R Anxiety Subscale 
SCL-Som = SCL-90-R Somatization Subscale 
SCL-Hos = SCL~90-R Hostility Subscale 












SCL- SCL- SCL- SCL-
Anx Som Host GSI 
. 
.02 -.09 .09 .01 
.09 -.03 .35* .30* 
.22 -.01 .22 .25 
-.01 -.01 -.01 .07 
.11 -.04 -.02 .11 
.06 -.02 -.07 .03 
.09 -.09 -.03 -.04 
.02 .19 -.07 .05 
.09 -.04 -.01 .06 
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Table Ill. Hierarchical Multiple Regression Analysis Predicting Patient 
Participant Adjustment (GSI) Controlling for AOL, Coping Strategy, 
Uncertain~ and Uncertain~/col!ing strategx interaction variable. 





3 Prob-Foe Coping 
4 MUIS 
5 MUIS x Prob-Foe 
Equation #2 
3 Emot-Foc Coping 
4 MUIS 
5 MUIS x Emot-Foc 
*.12 < . 05, **.12 < .01, ***.12 < .005 
AOL = Activities of Daily Living 
Prob-Foe Coping = Problem-Focused Coping Strategy 
Emot-Foc Coping = Emotion-Focused coping Strategy 










MUIS x Prob- (Emot) Foe = Mishel's Uncertainty in Illness Scale and Coping 
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Table IV. Hierarchical Multiple Regression Analysis Predicting Caregiver 
Participant Adjustment (GSI) Controlling for AOL, Coping Strategy, 
Uncertain!l and Uncertain!l/col?ing stratesx interaction variable. 





3 Prob-Foe Coping 
4 MUIS 
5 MUIS x Prob-Foe 
Equation#2 
3 Emot-Foc Coping 
4 MUI$ 
5 MUI$ x Emot-Foe 
*R < .01, **R < .001 
AOL = Activities of Daily Living 
Prob-Foe Coping = Problem-Focused Coping Strategy 
Emot-Foe Coping = Emotion-Focused coping Strategy 










MUIS x Prob- (Emot) Foe = Mishel's Uncertainty in Illness Scale and Coping 
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Table V. Hierarchical Multiple Regression Analysis Predicting Patient 
Participant Depression (100) Controlling for AOL, Coping strategy, 
Uncertain~, and Uncertain~coein9 strate9~ interaction variable. 





3 Prob-Foe Coping 
4 MUIS 
5 MUIS x Prob-Foe 
Equation #2 
3 Emot-Foc Coping 
4 MUIS 
5 MUIS x Emot-Foc 
*.12 < .05, **.Q < .005 
AOL = Activities of Daily Living 
Prob-Foe Coping = Problem-Focused Coping Strategy 
Emot-Foc Coping = Emotion-Focused coping Strategy 










MUIS x Prob- (Emot) Foe = Mishel's Uncertainty in Illness Scale and Coping 
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Table VI. Hierarchical Multiple Regression Analysis Predicting Caregiver 
Participant Depression (100) Controlling·tor AOL, Coping strategy, 
Uncertain!l, and Uncertain!l/coeing strateg~ interaction variable. 





3 Prob-Foe Coping 
4 MUIS 
5 MUIS x Prob-Foe 
Equation #2 
3 Emot-Foc Coping 
4 MUIS 
5 MUIS x Emot-Foc 
*Q < .05 
ADL = Activities of Daily Living 
Prob-Foe Coping = Problem-Focused Coping Strategy 
Emot-Foc Coping = Emotion-Focused coping Strategy 










MUIS x Prob- (Emot) Foe= Mishel's Uncertainty in Illness Scale and Coping 
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Table VII. Hierarchical Multiple Regression Analysis Predicting Patient 
Participant Adjustment (GSI) Controlling for the Caregiver Variables of 
Adjustment (GSI), Coping Strategy, and Uncertainty 
Equation #1 
Equation#2 
















2 Cr. Emot-Foc Coping -.03 .06 .05 
3 Cr. Uncertainty .18 .06 .35 
Cr. Adjustment = Caregiver Adjustment as measured by the SCL-90-R GSI subscale 
Cr. Prob-Foe Coping = Caregiver Problem-focused Coping Strategy 
Cr. Emot-Foc Coping = Caregiver Emotion-focused Coping Strategy 
Cr. Uncertainty= Caregiver level of uncertainty as measured by the MUIS 
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Table VIII. Hierarchical Multiple Regression Analysis Predicting Caregiver 
Participant Adjustment (GSI) Controlling for the Patient Variables of 
Adjustment (GSI), Coping Strategy, and Uncertainty. 
Step Predictor Variable B R2 Change F Change 
Equation #1 
1 Pt. Adjustment .15 .02 .67 
2 Pt. Prob-Foe Coping .49 .24 4.5* 
3 Pt. Uncertainty .16 .26 3.2* 
Equation #2 
2 Pt. Emot-Foc Coping .38 .07 .67 
3 Pt Uncertainty -.04 .04 2.2 
*.Q < .05 
Pt. Adjustment = Patient Adjustment as measured by the SCL-90-R GSI subscale 
Pt. Prob-Foe Coping = Patient Problem-focused Coping Strategy 
Pt. Emot-Foc Coping = Patient Emotion-focused Coping Strategy 
Pt. Uncertainty = Patient level of uncertainty as measured by the MUIS 
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Appendix A 
Consent for Participation 
I, , hereby voluntarily consent to participate (or, in 
cases of legal guardianship, sign consent for said individual) in the present research 
project. I understand that the purpose is to gain information regarding how individuals 
with Parkinson's Disease and their caregivers cope and adjust to the condition. In this 
study, I will be given a packet of questionnaires to complete that ask questions regarding 
the physical symptoms and emotional consequences related to the disease. Further, 
background information was solicited in order to determine if these factors contribute to 
how one adjusts to the stresses associated with a chronic illness such as Parkinson's 
Disease. 
Participation in this research is of minimal risk psychologically and represents no more 
risk than would be normally encountered in a routine psychological evaluation. 
I understand that I am free to withdraw from the study at any time (or withdraw said 
individual from participating) and that all information I provide will be kept confidential. All 
data cited by the researchers will emphasize group rather than individual performances. 
This research is being conducted by Neva Sanders Durazzo, M.S. under the 
supervision of Larry Mullins, Ph.D., in association with the Oklahoma State University's 
Department of Psychology. I understand that I am may contact either Neva Sanders 
Durazzo, M.S. at (405)744-6027, Larry Mullins at (405)744-6951, or Gay Clarkson, 
Executive Secretary, Oklahoma State University Research Services, 305 Whitehurst, 
(405)744-5700 if I wish further information regarding this research. 
I fully understand the information contained in this form as presented to me. I sign it 
freely and understand that my participation is completely voluntary. 
Signature of Subject (or legal guardian) Date 
I certify that I have personally explained all areas of this form prior to the subject signing 
it. 
Signature of Researcher Date 
Parkinson's Disease 86 
Appendix B (page 1 of 2) 
Please detach this piece of paper and keep it!! 
The researchers wish to thank you again for your participation. In the past, researchers 
have found that after completing questionnaires in some research projects some 
individuals notice behaviors or activities that they wish to change. Psychologists and 
other mental health professional can help you if you are experiencing difficulty or have 
some problems you would like to discuss. If you feel that you would like some help or 
need some more information about receiving services, please contact one of the 
following knowledgeable referral sources. 
Family Mental Health Center 
2725 E. Skelly Drive 
Tulsa, OK 7 4105 
(918)749-3030 or (918)749-8022 (V/TDD) 
Associated Centers for Therapy, INC. 
701 O S. Yale, Suite 215 
Tulsa, OK 7 4136-5705 
(918)492-2554 (V/TDD) 
Parkside. INC. 
1620 E. 12th 
Tulsa, OK 74120-5499 
(918)582-2131 (V/TDD} 
Star Community Mental Health Center 
3604 N. Cincinnati 
Tulsa, OK 74106-1536 
(918)452-5526 
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Appendix B (page 2 of 2) 
Information Statement 
This packet contains questionnaire items that are to be filled out specifically by the 
patient or the caregiver. Each set of questions begins with instructions for how to 
complete those items. Please read each of these statements carefully. If you are not 
sure how to answer an item- give it your best shot, please do not leave any items blank. 
If you are unsure what particular questions are asking of you, please ask one of the 
researchers. If you are completing this packet at home and have questions, please feel 
free to contact us at (405) 377-9759. 
**Patients- if you need any help in manually completing these forms, please ask your 
care provider to assist you. If this occurs, let your care provider fill out the items with the 
responses you provide them. 
**Caregivers- If the patient requires any assistance in manually completing these forms, 
please feel free to help them. If this occurs, please mark each item with the answers 
provided by the patient, not by how you think the patient would respond (unless they are 
unable to provide you with adequate information). 
Again, your participation is much appreciated. Results of this research will be presented 
in a future edition of the APDA newsletter. 
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Appendix C: 
Background Information-Patient 
Subj.# __ _ 
1. Name: ________ _ 
2. Date of Birth (moldy/yr): ____ _ 
3. Age: ___ _ 
4. Gender (circle one): Male Female 






6. If married, does your spouse work outside the home? (circle one) YES NO 
7. Do you currently work outside the home? (circle one): YES NO 
a. If YES, how many hours per week do you work? __ _ 
b. If NO, is this due to the Parkinson's disease? __ _ 
8. Annual income before taxes for individual 2! combined if married (check one): 






_$60,001 or more 
9. Highest level of education you obtained: 
_Less than 12 years (did not graduate High School) 
_Completed High school (12 years completed) 
_Less than one year of college 
_1-2 years of college course work 
_2-4 years of college course work 
_College Graduate (Bachelors degree obtained) 
_Some post-graduate work completed 
_Post graduate degree obtained (M.A., Ph.D., M.D., etc.) 
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THE FOLLOWING QUESTIONS ALL RELATE TO THE DIAGNOSIS OF PARKINSON'S 
DISEASE 
10. Age in years when Parkinson's disease was officially diagnosed: __ 
11. Number of years disease symptoms were present before diagnosis made: _ 
12. Years since Diagnosis: __ 
13. Are you currently taking medication for Parkinson's disease? YES NO 
14. Do you currently attend a Parkinson's disease support group? YES NO 






_Significant Other ("boyfriend" or "girlfriend") 
_No relation, individual is hired help 
16. Total years you have known the care provider: 





_more than 30 years 
17. Number of years you knew your care provider before you were diagnosed 
with PD: 
_did not know the individual prior to PD diagnosis 





_more than 30 years 
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Appendix D: 
Background Information-Caregiver 
Subj.# ____ _ 
1. Name: ---------------
2. Date of Birth (moldy/yr):. ____ _ 
3. Age: ___ _ 
4. Gender (circle one): Male Female 






6. If married, does your spouse work outside the home? (circle one) YES NO 
7. Do you currently work outside the home? (circle one): YES NO 
a. If YES, how many hours per week do you work? __ _ 
b. If NO, is this due to your taking care of the individual with PD? ___ _ 
8. Annual income before taxes for individual 2.£ combined if married (check one): 






_$60,001 or more 
9. Highest level of education you obtained: 
_Less than 12 years ( did not graduate High School) 
_Completed High school (12 years completed) 
_Less than one year of college 
_1-2 years of college course work 
_2-4 years of college course work 
_College Graduate (Bachelors degree obtained) 
_Some post-graduate work completed 
_Post graduate degree obtained (M.A., Ph.D., M.D., etc.) 
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THE FOLLOWING QUESTIONS ALL RELATE TO THE DIAGNOSIS OF PARKINSON'S 
DISEASE 
10. Age of the individual when they were officially diagnosed with Parkinson's 
disease: 
11. Number of years disease symptoms were present before diagnosis made: _ 
12. Years since Diagnosis:_ 
13. Is the individual currently taking medication for Parkinson's disease? YES NO 
14. Do you currently attend a Parkinson's disease support group? YES NO 






_Significant Other ("boyfriend" or "girlfriend") 
_No relation 
16. Total years you've known the individual with Parkinson's disease: 





_more than 30 years 
17. Number of years you knew the individual before they were diagnosed with 
PD: 
_did not know the individual prior to PO diagnosis 





_more than 30 years 
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AppendixE: 
INSTRUCTIONS 
1. On this questionnaire are groups of 5 statements. 
2. Read each group of statements carefully. Then Pick out the ONE statement in 
each group that best describes the way you have been feeling the PAST 
TWO WEEKS. Circle the number next to the statement you picked. 
**************************************************************************************************** 
1. o I do not feel sad or depressed. 
1 I occasionally feel sad or down. 
2 I feel sad most of the time, but I can snap out of it. 
3 I feel sad all the time, and I can't snap out of it. 
4 I am so sad or unhappy I can't stand it. 
2. O My energy level is normal. 
1 My energy level is occasionally a little lower than normal. 
2 I get tired more easily or have less energy than usual. 
3 I get tired from doing almost anything. 
4 I feel tired or exhausted almost all of the time. 
3. O I have not been feeling more restless and fidgety than usual. 
1 I feel a little more restless or fidgety than usual. 
2 I have been very fidgety, and I have some difficulty sitting still in a chair. 
3 I have been extremely fidgety, and have been pacing a little bit almost 
everyday. 
4 I have been pacing more than an hour per day, and I can't sit still. 
4. O I have not been talking or moving more slowly than usual. 
1 I am talking a little slower than usual. 
2 I am speaking slower than usual, and it takes me longer to respond to 
questions, but I can still carry on a normal conversation. 
3 Normal conversations are difficult because it is hard to start talking. 
4 I feel extremely slowed down p~ysically, like I am stuck in mud. 
5. O I have not lost interest in my usual activities. 
1 I am a little less interested in 1 or 2 of my usual activities. 
2 I am less interested in several of my usual activities. 
3 I have lost most of my interest in almost all my activities. 
4 I get no pleasure from any of the activities which I usually enjoy. 
6. O I get as much pleasure out of my activities as usual. 
1 I get a little less pleasure from 1 or 2 of my usual activities. 
2 I get less pleasure from several of my usual activities. 
3 I get almost no pleasure from most of the activities which I usually enjoy. 
4 I get no pleasure from any of the activities which I usually enjoy. 
7. O I have not been feeling guilty. 
1 I occasionally feel a little guilty. 
2 I often feel guilty. 
3 I feel quite guilty most of the time. 
4 I feel extremely guilty most of the time. 
8. o I do not feel like a failure. 
1 My opinion of myself is occasionally a little low. 
2 I feel like I am inferior to most people. 
3 I feel like a failure. 
4 I feel I am a totally worthless person. 
9. o I haven't had any thoughts of death or suicide. 
1 I occasionally think life is not worth living. 
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2 I frequently think of dying in passive ways (such as going to sleep and not 
waking up), or that I'd be better off dead. 
3 I have frequent thoughts of killing myself, but I would not carry them out. 
4 I would kill myself if I had the chance. 
10. O I can concentrate as well as usual. 
1 My ability to concentrate is slightly worse than usual. 
2 My attention span is not as good as usual and I am having difficulty 
collecting my thoughts, but this hasn't caused any problems. 
3 My ability to read or hold a conversation is not as good as it usually is. 
4 I cannot read, watch TV, or have a conversation without great difficulty. 
11. O I make decisions as well as I usually do. 
1 Decision making is slightly more difficult than usual. 
2 It is harder and takes longer to make decision, but I do make them. 
3 I am unable to make some decisions. 
4 I can't make any decisions at all. 
12. O My appetite is not less than normal. 
1 My appetite is slightly worse than usual. 
2 My appetite is clearly not as good as usual, but I still eat. 
3 My appetite is much worse now. 
4 I have no appetite at all, and I have to force myself to eat even a little. 
13. O I haven't lost any weight. 
1 I've lost less than 5 pounds. 
2 I've lost between 5-10 pounds. 
3 I've lost between 11-25 pounds. 
4 I've lost more than 25 pounds. 
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14. 0 My appetite is not greater than normal. 
1 My appetite is slightly greater than normal. 
2 My appetite is clearly greater than usual. 
3 My appetite is much greater than usual. 
4 I feel hungry all of the time. 
15. 0 I haven't gained any weight. 
1 I've gained less than 5 pounds. 
2 I've gained between 5-1 O pounds. 
3 I've gained between 11-25 pounds. 
4 I've gained more than 25 pounds. 
16. 0 I am not sleeping less than normal. 
1 I occasionally have slight difficulty sleeping. 
2 I clearly don't sleep as well as usual. 
3 I sleep about half my normal amount of time. 
4 I sleep less than 2 hours per night. 
17. 0 I am not sleeping more than normal. 
1 I occasionally sleep more than normal. 
2 I frequently sleep at least 1 hour more than usual. 
3 I frequently sleep at least 2 hours more than usual. 
4 I frequently sleep at least 3 hours more than usual. 
18. 0 I do not feel discouraged about the future. 
1 I occasionally feel a little discouraged about the future. 
2 I often feel discouraged about the future. 
3 I feel very discouraged about the future most of the time. 
4 I feel that the future is hopeless and that things will never improve. 
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Appendix F: 
Activities of Daily Living-Patient Version, Adapted 
Now I'd like to ask you about some of the activities of daily living, things that we all need 
to do as part of typical daily life. Your answers to these questions should be from your 
perspective--the level at which you can currently accomplish these tasks. I would like to 
know if you can do these activities without any help at all, with minimal help, or if you are 
no longer able to do these tasks at all. 
Be sure to read all of the choice alternatives and circle the letter of the answer that best 
describes your CURRENT abilities. 
1. When using the phone, I. .. 
a. need no help (can look up numbers and dial on my own). 
b. need some help (can answer phone, but need a special phone or help in 
getting a number or dialing). 
c. cannot use the phone at all (unable to do this task). 
2. For places that are out of walking distance, I ... 
a. need no help (can drive my own car or travel alone by bus/taxi). 
b. need some help (need someone to drive, get a taxi, locate the appropriate bus 
for me). 
c. cannot travel unless it is an emergency situation (in an ambulance). 
3. When shopping for groceries or clothes (assuming I have transportation), 
I. .. 
a. need no help (can do all aspects of shopping on own). 
b. need some help (someone must always go with me as I need help with some 
aspect of shopping such as writing a check or making a decision). 
c. cannot shop at all. 
4. When preparing meals, I ... 
a. need no help (can plan and cook full meals on own). 
b. need some help (can prepare some things, but can't cook full meals on own). 
c. cannot prepare meals at all. 
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5. For housework Qr odd jobs around the house, I... 
a. need no help (can scrub floors, vacuum, etc). 
b. need some help (can do easy tasks, but need help with more difficult tasks). 
c. cannot do any housework or odd jobs. 
6. When taking medicine, I ... 
a. need no help (take the correct dosage at the appropriate time). 
b. need some help (able to take medicine if someone prepares it for me or tells 
me when it is time to take it). 
c. cannot take medicine without total supervision. 
7. When handling money, I ... 
a. need no help (can balance the checkbook, pay bills, etc). 
b. need some help (can handle some minor day-to-day financial interactions, but 
can't balance the checkbook or pay bills). 
c. cannot handle money related issues. 
8. When eating, I ... 
a. need no help (able to feed myself completely). 
b. need some help (cutting, putting food in mouth, etc). 
c. cannot eat anything on my own (I rely on others to feed me). 
9. When dressing or undressing, I ... 
a. need no help (can pick out clothes, dress and undress self) 
b. need some help (for example, putting on socks, buttoning shirt). 
c. cannot dress or undress myself at all (others dress me). 
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10. For tasks associated with grooming/appearance, I ... 
a. need no help (can comb hair, brush teeth on own). 
b. need some help (assistance needed to apply make-up or shave). 
c. cannot maintain my appearance without full assistance. 
11. In tenns of walking, I ... 
a. need no help (completely ambulatory) 
b. need some help (use cane, crutches, or walker) 
c. cannot walk at all. 
12. When getting out of bed, I ... 
a. need no help. 
b. need some help (either from a person or a mechanical device). 
c. am totally dependent on someone or something to lift me. 
13. When taking a bath or shower, I ... 
a. need no help. 
b. need some help getting into/out of the tub, or use a special attachment in the 
tub. 
c. cannot bathe on own (rely on others to bathe me). 
14. I have trouble getting to the bathroom on time ... 
a. Never b. Rarely c. Occasionally d. Frequently 
15. The previous questions (1-14) were completed by ... 
a. the individual with PD. 
b. a caregiver completed the questions with the answers provided by the patient. 
c. a caregiver answered the questions based on his/her impressions of what the 
patient "would have" answered. 
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AppendixG: 
Activities of Daily Living-Caregiver Version, Adapted 
Now I'd like to ask you about some of the activities of daily living, things that we all need 
to do as part of typical daily life. Your answers to these questions should be from your 
perspective on how the individual with PD is currently able to accomplish these tasks. I 
would like to know if the individual can do these activities without any help at all, with 
minimal help, or if he/she can't do them at all. 
Be sure to read all of the choice alternatives and circle the letter of the answer that best 
describes the CURRENT abilities of the individual with PD. 
1. When using the phone, the individual with Parkinson's Disease (PD) 
typically ... 
a. needs no help (can look up numbers and dial on own). 
b. needs some help (can answer phone, but needs a special phone or help in 
getting a number or dialing). 
c. cannot use the phone at all (unable to do this task). 
2. For places that are out of walking distance, the individual with PD ... 
a. needs no help (can drive own car or travel alone by bus/ taxi). 
b. needs some help (needs someone to drive, get a taxi, locate the appropriate 
bus). 
c. cannot travel unless emergency situation (in an ambulance). 
3. . When shopping for groceries or clothes (assuming they have 
transportation), the individual with PD ••. 
a. needs no help (can do all aspects of shopping on own). 
b. needs some help (someone must always go with him/her as help is needed 
with some aspect of shopping such as writing a check or making a decision). 
c. cannot shop at all. 
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4. When preparing meals, the individual with PD ... 
a. needs no help (can plan and cook full meals on own). 
b. needs some help (can prepare some things, but can't cook full meals alone). 
c. cannot prepare any meals at all. 
5. For housework .2! odd jobs around the house, the individual with PD ... 
a. needs no help (can scrub floors, vacuum, etc). 
b. needs some help (can do easy tasks, but needs help with more difficult tasks). 
c. cannot do any housework or odd jobs. 
6. When taking medicine, the individual with PD .... 
a. needs no help (takes the correct dosage at the appropriate time). 
b. needs some help (able to take medicine if someone prepares it for him/her and 
prompts the individual when it is time to take it). 
c. cannot take medicine without total supervision. 
7. When handling money, the individual with PD ... 
a. needs no help (can balance the checkbook, pay bills, etc). 
b. needs some help (can handle some minor day-to-day financial interactions, but 
can't balance the checkbook or pay bills). 
c. cannot handle money related issues. 
8. When eating, the individual with PD ... 
a. needs no help (able to feed self completely). 
b. needs some help (cutting, putting food in mouth, etc). 
c. cannot eat anything on own (relies on others to feed him/her). 
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9. When dressing or undressing, the individual with PD ... 
a. needs no help (can pick out clothes, dress and undress self) 
b. needs some help (for example, putting on socks, buttoning shirt). 
c. cannot dress or undress self at all (others must dress him/her). 
10. For tasks associated with grooming/appearance, the individual with PD •.• 
a. needs no help (can comb hair, brush teeth on own). 
b. needs some help (assistance needed to apply make-up or shave). 
c. cannot maintain his/her appearance without full assistance. 
11. In terms of walking, the individual with PO ... 
a. needs no help (completely ambulatory) 
b. needs some help (uses cane, crutches, or walker) 
c. cannot walk at all. 
12. When getting out of bed, the individual with PD ... 
a. needs no help. 
b. needs some help (either from a person or a mechanical device). 
c. is totally dependent on someone or something to lift him/her. 
13. When taking a bath or shower, the individual with PD ... 
a. needs no help. 
b. needs some help getting into/out of the tub, or uses special attachments in tub. 
c. cannot bathe on own {relies on others to bathe him/her). 
14. Does the individual with PD have trouble getting to the bathroom on time? 
a. Never b. Rarely c. Occasionally d. Frequently 
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Appendix H: Clinical Disability Scale 
Please place a mark next to the category that best describes the characteristics 
demonstrated by the individual with Parkinson's disease. Only place an X next to one of 
the categories (1,11,111,IV or 
V)·-------------------
- I. Only one side of the body appears to be affected at the present time. The 
patient shows minimal or no functional impairment the majority of the time. 
Characteristics of individuals identified by this category: 
_symptoms of PD rarely exhibited and on only ONE side of the body. 
_people who don't know the patient well probably wouldn't know they had PD. 
_minor weakness, aches, or stiffness on one side of the body (daily tasks unaffected). 
_ability to walk is not affected. 
_ II. Both sides of body appear to be affected, but only minimally. The patient 
demonstrates no impairment of balance. 
· Characteristics of individuals identified by this category: 
_symptoms of PD demonstrated on both sides of body (e.g., tremors in both hands, 
weakness in both legs). 
_may demonstrate minor stoop in posture that does not effect balance. 
_no difficulties in balance when either standing or walking. 
_ Ill. Both sides of body are effected. Patient demonstrates an unsteadiness when 
attempting to turn while standing. If patient was given a slight push while standing with 
feet together and eyes closed, they would have difficulty regaining balance. The patient 
is somewhat restricted in ability to perform daily activities, but is capable of leading an 
independent life. 
Characteristics of individuals identified by this category: 
_symptoms of PD hinder the patient's ability to perform tasks as easily as they once 
did (e.g., driving, exercising, cutting/preparing food). 
_lives independently without others fearing safety (i.e., no fear of patient falling down 
stairs due to motor weakness, or unable to eat since can't prepare any food for self). 
_symptoms are not severe enough to effect ability to drive or maintain employment. 
_ IV. Symptoms of PD are fully developed and greatly impede patient's ability to 
function normally. Disease has severely debilitated the patient in that they are markedly 
incapacitated, yet, they are still able to walk/stand with minimal assistance. 
Characteristics of individuals identified by this category: 
_may need ~ assistance when dressing 
_still able to maintain physical appearance on own (brush hair, wash face). 
_patient no longer able to drive or work outside the home. 
_demonstrates decreased involvement in social activities. 
_utilizes a cane for mobility. 
_marked impairment in penmanship 
_ V. Patient requires assistance in most or all areas of living. He/she is typically 
confined to a bed or a wheelchair unless considerable assistance is provided. 
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Characteristics of individuals identified by this category: 
_utilizes wheelchair for mobility or is confined to a bed. 
_relies on others to feed, dress, bathe him/her. 
_unable to write legibly. 
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Appendix I: 







Please read each statement. Take your time and think about what each 
statement says. When place an "X" under the column that most closely 
indicates how you are feeling TODAY. If you agree with a statement, 
then you would mark under either "Strongly Agree" or "Agree." If you 
disagree with a statement, then mark under either "Strongly Disagree" or 
"Disagree." If you are undecided about how you feel, then mark under 
"Undecided" for that statement. Please respond to every statement. 
I don't know what is wrong with me. 
Strongly Agree Agree Undecided Disagree Strongly Disagree 
(5) (4) (3) (2) (1) 
I have a lot of questions without answers. 
Strongly Agree Agree Undecided Disagree Strongly Disagree 
(5) (4) (3) (2) (1) 
I am unsure if my illness is getting better or worse. 
Strongly Agree Agree Undecided Disagree Strongly Disagree 
(5) (4) (3) (2) (1) 
It is unclear how bad my symptoms will be. 
Strongly Agree Agree Undecided Disagree Strongly Disagree 
(5) (4) (3) (2) (1) 




















7. My symptoms seem to change unpredictably. 
Strongly Agree Agree Undecided Disagree 
(5) (4) (3) (2) 
8. I understand everything explained to me. 
Strongly Agree Agree Undecided Disagree 
(5) (4) (3) (2) 







9. The doctors say things to me that could have many meanings. 
Strongly Agree Agree' Undecided Disagree Strongly Disagree 
(5) (4) (3) (2) (1) 
10. My treatment is too complex to figure out. 
Strongly Agree Agree Undecided Disagree Strongly Disagree 
(5) (4) (3) (2) (1) 
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14. I have been given many differing opinions about what is wrong with me. 
Strongly Agree Agree Undecided Disagree 
(5) (4) (3) (2) 
15. It is not clear what is going to happen to me. 
Strongly Agree Agree Undecided Disagree 
(5) (4) (3) (2) 
16. The results of my tests are inconsistent. 
Strongly Agree Agree Undecided Disagree 
(5) (4) (3) (2) 
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AppendixJ: 





Please read each statement. Take your time and think about what 
each statement says. Then place an "X" ·under the column that most 
closely indicates how you are feelin.g about the individual with 
Parkinson's Disease TODAY. If you agree with a statement, then you 
would mark under either "Strongly Agree" or "Agree." If you disagree 
with a statement, then mark under either "Strongly Disagree" or 
"Disagree." If you are undecided about how you feel about the 
individual with PD, then mark under "Undecided" for that statement. 
Please respond to every statement. 
I don't know what is wrong with him/her. 
Strongly Agree Agree Undecided Disagree Strongly Disagree 
(5) (4) (3) (2) (1) 
I have a lot of questions without answers. 
Strongly Agree Agree Undecided Disagree Strongly Disagree 
(5) (4) (3) (2) (1) 
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Strongly Disagree 
(1) 










8. His/her symptoms continue to change unpredictably. 
Strongly Agree Agree Undecided Disagree 
(5) (4) (3) (2) 
9. I understand everything explained to me. 
Strongly Agree Agree Undecided Disagree 
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Strongly Disagree 
(1) 
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Appendix K: 
Revised Ways of Coping Checklist 
In order for this questionnaire to have meaning, it is necessary that you first list 
an event/person /experience that is currently of concern to you. Please list the major 
stressor in your life. 
The items below represent ways that you may have dealt with the stressor you 
listed above. We are interested in the degree to which you have used each of the 
thoughts/behaviors represented in these items in order to deal with the stressor you 
listed above. Please check the appropriate column if the thought/behavior was never 
used, rarely used, sometimes used, or regularly used. 
THOUGHTS/BEHAVIORS 
1. Bargained or compromised to get 
something positive from the situation. 
2. Talked to someone to find out about 
the situation 
3. Blamed myself. 
4. Concentrated on something good that 
could come out of the whole thing. 
5. Criticized or lectured myself. 
6. Tried not to bum my bridges behind me, 
but left things open somewhat. 
7. Hoped a miracle would happen. 
8. Asked someone I respected for 
advice and followed it. 
9. Kept others from knowing how bad 
things were. 
10. Talked to someone about how I was 
feeling. 
11. Stood my ground and fought for what 
I wanted. 










13. I knew what had to be done, so I doubled 
my efforts and tried harder to make things 
work. 
14. Refused to believe that it had happened .. __ 
15. Came up with a couple of different 
solutions to the problem. 
16. Wished I were a stronger person-more 
optimistic and forceful. 
17. Accepted by strong feelings, but didn't 
let them interfere with other things 
too much. 
18. Wished that 1 · could change what had 
happened. 
19. Wished that I could change the way that 
I felt. 
20. Changed something about myself so that 
I could deal with the situation better. 
21. Daydreamed or imagined a better time or 
place than the one I was in. 
22. Had fantasies or wished about how things 
might turn out. 
23. Thought about fantastic or unreal things 
(like the perfect revenge or finding a million 
dollars) that made me feel better. 
24. Wished that the situation would go away 
or somehow be finished. 
25. Went on as if nothing had happened. 
26. Felt bad that I couldn't avoid the problem __ 
27. Kept my feelings to myself. 
28. Slept more than usual. 
Rarely 
Used 




29. Got mad at other people or things that 
caused the problem. 
30. Accepted sympathy and understanding 
from someone. 
31. Tried to forget the whole thing. 
32. Got professional help and did what 
what they recommended. 
33. Changed or grew as a person in a 
good way. 
34. Made a plan of action and followed it. 
35. Accepted the next best thing to what 
what I wanted. 
Never 
Used 
36. Realized I brought the problem on myself __ 
37. Came out of the experience better than 
I went in. 
38. Talked to someone who could do something 
concrete about the problem. 
39. Tried to make myself feel better by eating, 
drinking, smoking, taking medication, etc __ 
40. Tried not to act too hastily or follow my 
own hunch. 
41. Changed something so that things would 
turn out all right. 
42. Avoided being with people in general. 
43. Made light out of the situation; refused 
to get too serious about it. 
44. Didn't let it get to me; refused to think 
about it too much. 
45. Joked about it. 
Rarely 
Used 





46. Accepted it, since nothing could be done __ 
4 7. Looked for the "silver lining," so to speak; 
tried to look on the bright side of things. __ 
48. Went along with fate; sometimes you just 
have bad luck. 
49. Got made at the people or things that 
caused the problem. 
50. Took it out on others. 
51. Figured out who to blame. 
52. Blamed others. 
53. Found out what other person was 
responsible. 
54. Thought that others were unfair to me. 
55. Thought how much better off I am than 
others. 
56. Told myself things could be worse. 
57. Told myself how much I have already 
accomplished. 
58. Focused on the good things in my life. 
59. Counted my blessings. 
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Sometimes Regularly 
Used Used 
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In response to the following question, please check the degree to which the statements 
below apply to the stressor you previously listed. 
"In general, the stressor that I listed above is one that ... " : 
Strongly Both Agree & 
Disagree Disagree Disagree Agree 
1 .... I can change or do 
something about it. 
2 .... I must accept or get used 
to it. 
3 .... I need to know more before 
I can act. 
4. . .. requires that I hold myself back 
from doing what I want to. __ _ 
5 .... is very important to me. __ _ 
6 .... I have some control over ---
7. . .. will be resolved in one year. 
8. . .. will be resolved in four years. 
9 .... I think about often. 
1 O ... will always be a problem in 
my life. 
11 .. .is very threatening. 
12 ... I have experienced before. 
13 ... is ambiguous. 
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